RESULT_COUNT: 435,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
ARRY,ARRY:US,BBG000C52TW3,Today's Research Reports on Trending Tickers: Array BioPharma and Spectrum Pharmaceuticals,2017-10-18 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000662.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 18, 2017 / The Dow Jones Industrial Average crossed the 23,000 plateau for the first time ever on Tuesday as investors digested the latest batch of corporate earnings. ..."
ARRY,ARRY:US,BBG000C52TW3,"After Hours Most Active for Oct 16, 2017 :  NFLX, PE, F, MAR, ISBC, LB, GE, SYF, LUV, CMCSA, QQQ, ARRY",2017-10-16 21:05:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VGRwBDcu-6g/after-hours-most-active-for-oct-16-2017-nflx-pe-f-mar-isbc-lb-ge-syf-luv-cmcsa-qqq-arry-cm860357,The NASDAQ 100 After Hours Indicator is up 1 08 to 6 115 61 The total After hours volume is currently 51 926 396 shares traded The following are the most active stocks for the after hours session Netflix Inc NFLX is 3 45 at 206 13 with 2 928 313 shares traded
ARRY,ARRY:US,BBG000C52TW3,Loxo Oncology Fights Cancer With 'Tumor Agnostic' Approach,2017-10-16 13:18:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZWZQE2Dkqv4/loxo-oncology-fights-cancer-with-tumor-agnostic-approach-cm859981,The potential cancer cure disclosures that propelled Loxo Oncology LOXO stock up 43 one day in June and an additional 15 one day in September indicate innovation in cancer research and treatment that many investors say could keep Loxo aloft ibd display video id
ARRY,ARRY:US,BBG000C52TW3,"ETFs with exposure to Array BioPharma, Inc. : October 9, 2017",2017-10-09 15:16:47 +0000,http://finance.yahoo.com/r/37f02baa-f04f-3b43-84f9-05b0c02b0b9e/etfs-with-exposure-to-array-biopharma-inc-october-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-10-09 12:03:51 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120351609.html?.tsrc=rss,Array Biopharma Inc NASDAQ NMS:ARRY
ARRY,ARRY:US,BBG000C52TW3,Steven Cohen Doubles Down on Sickle Cell Disease Therapeutics Company Global Blood,2017-10-05 12:47:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r0n3RUTT4eM/steven-cohen-doubles-down-on-sickle-cell-disease-therapeutics-company-global-blood-cm855548,On Oct 2 Steven Cohen Trades Portfolio increased his Global Blood Therapeutics Inc GBT position according to GuruFocus real time picks On Oct 2 Steven Cohen Trades Portfolio increased hisGlobal Blood Therapeutics Inc Global Blood Therapeutics Inc
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-10-04 12:02:47 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120330947.html?.tsrc=rss,Array Biopharma Inc NASDAQ NMS:ARRY
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-10-02 12:02:21 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120221439.html?.tsrc=rss,Array Biopharma Inc NASDAQ NMS:ARRY
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-09-29 12:04:09 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120409904.html?.tsrc=rss,Array Biopharma Inc NASDAQ NMS:ARRY
ARRY,ARRY:US,BBG000C52TW3,"After Hours Most Active for Sep 28, 2017 :  BAC, F, INTC, NWL, CPN, WFC, NEE^R, ARRY, HOMB, ACWI, ZNGA, CSX",2017-09-28 21:02:49 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6cw_7ehcKdo/after-hours-most-active-for-sep-28-2017-bac-f-intc-nwl-cpn-wfc-neer-arry-homb-acwi-znga-csx-cm852868,The NASDAQ 100 After Hours Indicator is up 97 to 5 934 04 The total After hours volume is currently 41 787 336 shares traded The following are the most active stocks for the after hours session Bank of America Corporation BAC is 0 02 at 25 47 with 5 495 109
ARRY,ARRY:US,BBG000C52TW3,Today's Research Reports on Trending Tickers: Array BioPharma and Horizon Pharma,2017-09-28 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000760.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 28, 2017 / Large-cap and small-cap stocks soared to new intra-day records Wednesday as financial stocks surged after Republicans released details on tax reform. The ..."
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-09-26 12:04:11 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120411569.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
ARRY,ARRY:US,BBG000C52TW3,"Cramer's lightning round: I like Altria Group, but it's n...",2017-09-20 23:07:00 +0000,https://finance.yahoo.com/video/cramers-lightning-round-altria-group-230700924.html?.tsrc=rss,"Jim Cramer flies through his take on callers' favorite stocks, including one tobacco giant."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The 2017 Cantor Fitzgerald Global Healthcare Conference,2017-09-19 14:00:00 +0000,https://finance.yahoo.com/news/array-biopharma-present-2017-cantor-140000376.html?.tsrc=rss,"BOULDER, Colo. , Sept. 19, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer , will present at the 2017 Cantor Fitzgerald Global Healthcare ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares,2017-09-19 13:09:00 +0000,https://finance.yahoo.com/news/array-biopharma-announces-closing-public-130900472.html?.tsrc=rss,"BOULDER, Colo. , Sept. 19, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) announced today the closing of its underwritten public offering of 24,069,766 shares of its common stock, which includes ..."
ARRY,ARRY:US,BBG000C52TW3,Mirati Skyrockets On Positive Data - Biotech Movers,2017-09-15 13:24:00 +0000,http://finance.yahoo.com/r/ae6cdd3f-2ec6-3589-9763-88f295a53130/mirati-jumps-on-positive-data.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The San Diego firm is scheduled to present positive preliminary data for two clinical studies of sitravatinib in non-small cell lung cancer at a symposium in Chicago on Friday.
ARRY,ARRY:US,BBG000C52TW3,"Pre-Market Most Active for Sep 15, 2017 :  ARRY, NOK, CS, SKM, TTOO, TVIX, NVDA, STAR, USLV, MFGP, MRNS, CUK",2017-09-15 12:55:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kHFVT3m3gcs/pre-market-most-active-for-sep-15-2017-arry-nok-cs-skm-ttoo-tvix-nvda-star-uslv-mfgp-mrns-cuk-cm846180,The NASDAQ 100 Pre Market Indicator is up 97 to 5 969 79 The total Pre Market volume is currently 4 576 758 shares traded The following are the most active stocks for the pre market session Array BioPharma Inc ARRY is 0 42 at 11 22 with 581 922 shares traded
ARRY,ARRY:US,BBG000C52TW3,Today's Research Reports on Stocks to Watch: Halozyme Therapeutics and Array Biopharma,2017-09-15 12:20:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-122000173.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 15, 2017 / Shares of Halozyme hit a new high yesterday and closed the day up over 20% after announcing not one, but three big pieces of news that had traders excited. ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Pricing of Public Offering of Common Stock,2017-09-14 23:17:00 +0000,https://finance.yahoo.com/news/array-biopharma-announces-pricing-public-231700256.html?.tsrc=rss,"The offering is expected to close on or about September 19, 2017, subject to customary closing conditions.  Array also granted the underwriters a 30-day option to purchase up to 3,139,534 additional shares of common stock.  All of the shares sold in the offering are being sold by Array."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Shows Significant Rebound After Initial Sell-Off,2017-09-14 15:54:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y_aAMksyNjg/array-biopharma-shows-significant-rebound-after-initial-selloff-20170914-01138,Array BioPharma Shows Significant Rebound After Initial Sell-Off
ARRY,ARRY:US,BBG000C52TW3,Colorado biotech plans $200 million stock offering,2017-09-14 13:53:34 +0000,http://finance.yahoo.com/r/23a47952-ac89-3985-8b86-eb658942669d/colorado-biotech-plans-200-million-stock-offering.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"A Boulder biotech said it's commenced an underwritten public offering of about $200 million of its stock.  Array BioPharma Inc. said it's begun an offering of $175 million of shares of its common stock, and it's giving underwriters the option to buy up to an additional $26 million in shares.  In the SEC filing, Array officials said the company's stock price will probably not remain stable."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Slides on Secondary Offering,2017-09-14 13:15:15 +0000,https://finance.yahoo.com/news/array-biopharma-slides-secondary-offering-131515289.html?.tsrc=rss,Array BioPharma saw its shares turn negative early on Thursday after the firm announced a secondary offering.
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma shares slide on secondary offering announcement,2017-09-13 21:13:16 +0000,http://finance.yahoo.com/r/9afa60a7-cf5c-3f85-8fca-5b113cdd4b98/Story.aspx?guid=B15DCD02-346E-4923-A248-AD7771B6B2AA&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Array BioPharma Inc.  shares fell in the extended session Wednesday after the drug developer announced a secondary offering of its shares. Array shares fell 7.9% to $9.70 after hours. The company ...
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Proposed Public Offering of Common Stock,2017-09-13 20:01:00 +0000,https://finance.yahoo.com/news/array-biopharma-announces-proposed-public-200100153.html?.tsrc=rss,"BOULDER, Colo., Sept. 13, 2017 /PRNewswire/ -- Array BioPharma Inc. (ARRY) today announced that it has commenced an underwritten public offering of $175,000,000 of shares of its common stock.  Array BioPharma also intends to grant the underwriters a 30-day option to purchase up to an additional $26,250,000 of shares of its common stock offered in the public offering.  All of the shares in the offering are to be sold by Array BioPharma."
ARRY,ARRY:US,BBG000C52TW3,Array's NDAs for Melanoma Combo Accepted for Review by FDA,2017-09-13 16:39:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-x6R-Qh33tw/arrays-ndas-for-melanoma-combo-accepted-for-review-by-fda-cm845165,Array BioPharma ARRY announced that the FDA has accepted for review its two New Drug Applications NDAs seeking approval for the combination of binimetinib 45 mg twice daily and encorafenib 450 mg once daily COMBO450 to treat patients with BRAF mutant advanced unresectable or
ARRY,ARRY:US,BBG000C52TW3,Steven Cohen Dives Into Array BioPharma,2017-09-13 16:08:24 +0000,https://finance.yahoo.com/news/steven-cohen-dives-array-biopharma-160824588.html?.tsrc=rss,Guru keeps adding to positions in health care industry
ARRY,ARRY:US,BBG000C52TW3,Array&apos;s NDAs for Melanoma Combo Accepted for Review by FDA,2017-09-13 14:47:02 +0000,https://finance.yahoo.com/news/array-apos-ndas-melanoma-combo-144702392.html?.tsrc=rss,"Array BioPharma&apos;s (ARRY) new drug applications for the combination of binimetinib and encorafenib to treat melanoma, accepted for review by the FDA."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces FDA Acceptance For Review Of Binimetinib And Encorafenib New Drug Applications For Patients With Advanced BRAF-mutant Melanoma,2017-09-12 13:09:00 +0000,https://finance.yahoo.com/news/array-biopharma-announces-fda-acceptance-130900028.html?.tsrc=rss,"BOULDER, Colo. , Sept. 12, 2017 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review its New Drug Applications (NDAs) ..."
ARRY,ARRY:US,BBG000C52TW3,3 Soaring Healthcare Stocks With Very Bullish News Sentiment,2017-09-12 13:07:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6sWZqo5stVQ/3-soaring-healthcare-stocks-with-very-bullish-news-sentiment-cm844204,"Shutterstock photo    What’s the effect of news— good   or   bad —on a stock’s price? A recent study by data scientists at the Fed revealed that positive news stories increase stock returns quickly, but negative stories have a long-delayed reaction. Specifically, positive news affects stock prices within a week."
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-09-12 12:02:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120242318.html?.tsrc=rss,"The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.  Index (PMI) data, output in the Healthcare sector is rising."
ARRY,ARRY:US,BBG000C52TW3,"ETFs with exposure to Array BioPharma, Inc. : September 12, 2017",2017-09-12 00:56:20 +0000,http://finance.yahoo.com/r/d59d16f4-ca91-327e-8ca1-664e09593784/etfs-with-exposure-to-array-biopharma-inc-september-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma And Others Shine At The ESMO 2017 Congress,2017-09-11 17:30:48 +0000,https://finance.yahoo.com/news/array-biopharma-others-shine-esmo-173048019.html?.tsrc=rss,"The 2017 ESMO Congress wraps up on Tuesday in Madrid, Spain. On Monday, Jefferies issued a handful of flash notes related to companies presenting at the conference. Here’s a breakdown of the highlights. ..."
ARRY,ARRY:US,BBG000C52TW3,Today's Research Reports on Stocks to Watch: Array BioPharma and Kura Oncology,2017-09-11 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000318.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 11, 2017 / It was a positive day for both Array BioPharma (NASDAQ: ARRY ) and Kura Oncology (NASDAQ: KURA ) this past Friday, after the companies released encouraging ..."
ARRY,ARRY:US,BBG000C52TW3,"New Hope For AZN's Old Drug, More About BMY's Opdivo, IMDZ On Watch",2017-09-11 00:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YSrwGw-FWiI/new-hope-for-azns-old-drug-more-about-bmys-opdivo-imdz-on-watch-20170911-00011,"New Hope For AZN's Old Drug, More About BMY's Opdivo, IMDZ On Watch"
ARRY,ARRY:US,BBG000C52TW3,Phase 3 COLUMBUS Part 2 Results in BRAF-Mutant Melanoma Presented at European Society for Medical Oncology Congress,2017-09-09 13:30:00 +0000,https://finance.yahoo.com/news/phase-3-columbus-part-2-133000061.html?.tsrc=rss,- Median PFS for patients on combination of binimetinib (45 mg) plus encorafenib (300 mg) was 12.9 months versus 9.2 months for patients on encorafenib (300 mg) - - Generally well-tolerated and safety ...
ARRY,ARRY:US,BBG000C52TW3,Array Resumes Trades After Unveiling Data In Colon Cancer Trial,2017-09-08 20:35:43 +0000,http://finance.yahoo.com/r/4bc470db-f522-37cd-b744-a9942aa809b6/array-halted-pending-news-ahead-of-key-data-in-cancer-trials-2?src=A00220&yptr=yahoo&.tsrc=rss,Array shares were halted early Friday pending news likely tied to data regarding its Phase 3 trials in colon cancer and melanoma.
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q4, 2017 By the Numbers : September 8, 2017",2017-09-08 20:31:48 +0000,http://finance.yahoo.com/r/fee2fa14-a9c8-3728-8450-84c55436847d/array-biopharma-inc-arry-us-earnings-analysis-q4-2017-by-the-numbers-september-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Array BioPharma, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Array BioPharma, Inc. – Celgene Corporation, Amgen Inc., Novartis AG Sponsored ADR, Astrazeneca PLC Sponsored ADR, Onconova Therapeutics Inc., Eli Lilly and Company and Cascadian Therapeutics Inc. (CELG-US, ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,Phase 3 BEACON CRC Safety Lead-In Results in BRAF-Mutant Colorectal Cancer Presented at European Society for Medical Oncology Congress,2017-09-08 16:58:00 +0000,https://finance.yahoo.com/news/phase-3-beacon-crc-safety-165800464.html?.tsrc=rss,"- 41% confirmed ORR for patients on combination of binimetinib, encorafenib and cetuximab - - Median duration of treatment was 5.6 months at time of analysis and 76% of patients remain on study treatment ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Seems to Be in a New Uptrend,2017-09-08 12:14:00 +0000,http://finance.yahoo.com/r/cbeeed9e-f26c-35cd-90dc-70a37819b190/array-biopharma-seems-be-new-uptrend?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,I really like how these three charts are shaping up on Array.
ARRY,ARRY:US,BBG000C52TW3,What's Behind Array Biopharma Inc.'s 31% Rally in August?,2017-09-06 21:51:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0UKajaOtY2g/whats-behind-array-biopharma-incs-31-rally-in-august-cm841969,What happened Shares of Array Biopharma Inc NASDAQ ARRY a biopharmaceutical company developing new cancer therapies gained 30 5 in August according to data from S amp P Global Market Intelligence More details from new drug candidates that could become this company
ARRY,ARRY:US,BBG000C52TW3,"Notable Wednesday Option Activity: TRTN, DAL, ARRY",2017-09-06 20:51:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QI5f_NjzcU8/notable-wednesday-option-activity-trtn-dal-arry-cm841906,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Triton International Ltd Symbol TRTN where a total volume of 1 944 contracts has been traded thus far today a contract volume which is representative of approximately 194
ARRY,ARRY:US,BBG000C52TW3,What&apos;s Behind Array Biopharma Inc.&apos;s 31% Rally in August?,2017-09-06 19:10:00 +0000,http://finance.yahoo.com/r/140b1d1d-c371-3f70-a7b1-db7143d5d839/why-array-biopharma-inc-stock-swelled-31-in-august.aspx?yptr=yahoo&.tsrc=rss,The company&apos;s lead candidates took another step forward last month.
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-09-06 12:02:31 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120231029.html?.tsrc=rss,Array Biopharma Inc NASDAQ NMS:ARRY
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At Wells Fargo Conference; Webcast At 9:05 AM ET,2017-09-06 08:06:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YUB08TxHbwE/array-biopharma-to-present-at-wells-fargo-conference-webcast-at-905-am-et-20170906-00569,Array BioPharma To Present At Wells Fargo Conference; Webcast At 9:05 AM ET
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma To Present BEACON CRC Safety Lead-in And COLUMBUS Part 2 Results At European Society For Medical Oncology Congress (ESMO),2017-08-30 12:00:00 +0000,https://finance.yahoo.com/news/array-biopharma-present-beacon-crc-120000449.html?.tsrc=rss,"- Array to host investor reception and webcast during ESMO on September 9 - BOULDER, Colo. , Aug. 30, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The 2017 Wells Fargo Healthcare Conference,2017-08-28 18:00:00 +0000,https://finance.yahoo.com/news/array-biopharma-present-2017-wells-180000156.html?.tsrc=rss,"BOULDER, Colo. , Aug. 28, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer , will present at the 2017 Wells Fargo Healthcare Conference.  ..."
ARRY,ARRY:US,BBG000C52TW3,"Friday's ETF Movers: OIH, XBI",2017-08-25 20:40:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RO3_0Y9iRhE/fridays-etf-movers-oih-xbi-cm837393,In trading on Friday the Oil Services ETF OIH is outperforming other ETFs up about 1 8 on the day Components of that ETF showing particular strength include shares of Carbo Ceramics CRR up about 6 9 and shares of Oceaneering International OII up about 4 5 on the
ARRY,ARRY:US,BBG000C52TW3,"ETFs with exposure to Array BioPharma, Inc. : August 24, 2017",2017-08-24 18:58:17 +0000,http://finance.yahoo.com/r/3f640c0a-6279-3e50-bf50-0fe89b1536e1/etfs-with-exposure-to-array-biopharma-inc-august-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,Harry Boxer: These three biotech stocks are breaking out,2017-08-24 16:51:09 +0000,http://finance.yahoo.com/r/fd52447e-7e8d-31dc-b7ea-0975a7ddfa5d/Story.aspx?guid=FCE75884-88E5-11E7-BE2B-E61E532BE66C&siteid=yhoof2&yptr=yahoo&.tsrc=rss,"In focus: Array BioPharma, Immunomedics and Spark Therapeutics."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) Looks Good: Stock Adds 5.9% in Session,2017-08-24 14:43:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IjcpwFf9wiU/array-biopharma-arry-looks-good-stock-adds-59-in-session-cm836445,Array BioPharma Inc ARRY was a big mover last session as the company saw its shares rise nearly 6 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up 22 3 in
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) Looks Good: Stock Adds 5.9% in Session,2017-08-24 12:44:12 +0000,https://finance.yahoo.com/news/array-biopharma-arry-looks-good-124412647.html?.tsrc=rss,"Array BioPharma (ARRY) shares rose nearly 6% in the last trading session, amid huge volumes."
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-08-23 12:02:48 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120248549.html?.tsrc=rss,Array Biopharma Inc NASDAQ NMS:ARRY
ARRY,ARRY:US,BBG000C52TW3,"3 Big Stock Charts for Wednesday: Amazon.com, Inc. (AMZN), Array Biopharma Inc (ARRY) and Paychex, Inc. (PAYX)",2017-08-16 21:35:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CuHoDq0xH20/3-big-stock-charts-for-wednesday-amazoncom-inc-amzn-array-biopharma-inc-arry-and-paychex-inc-payx-cm833040,InvestorPlace Stock Market News Stock Advice amp Trading Tips The market s indecisive moves have stocks bouncing around like a loose golf ball in a trunk Volatility with little actual movement is what drives traders absolutely nuts which is why we re maintaining a vigil
ARRY,ARRY:US,BBG000C52TW3,Edited Transcript of ARRY earnings conference call or presentation 9-Aug-17 1:00pm GMT,2017-08-16 18:21:16 +0000,https://finance.yahoo.com/news/edited-transcript-arry-earnings-conference-023033818.html?.tsrc=rss,Q4 2017 Array Biopharma Inc Earnings Call
ARRY,ARRY:US,BBG000C52TW3,"3 Big Stock Charts for Wednesday: Amazon.com, Inc. (AMZN), Array Biopharma Inc (ARRY) and Paychex, Inc. (PAYX)",2017-08-16 17:05:28 +0000,https://finance.yahoo.com/news/3-big-stock-charts-wednesday-170528758.html?.tsrc=rss,"Today’s three big stock charts look at the technical pictures for Amazon.com, Inc.(NASDAQ:AMZN), Array Biopharma Inc (NASDAQ:ARRY) and Paychex, Inc. (NASDAQ:PAYX) as each of these companies are trading in their own technical worlds that are providing clearer signals than the market in terms of tradable moves.  Overhead resistance in the form of the stock’s round-numbered $1,000 price has held, triggering selling pressure last week that rolled Amazon stock back lower.  Array Biopharma is showing signs that the recent rally is one that is likely to gain even more momentum, here’s why."
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-08-16 12:02:12 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120431571.html?.tsrc=rss,Array Biopharma Inc NASDAQ NMS:ARRY
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Appoints Curtis Oltmans As General Counsel,2017-08-14 21:00:00 +0000,https://finance.yahoo.com/news/array-biopharma-appoints-curtis-oltmans-210000615.html?.tsrc=rss,"BOULDER, Colo. , Aug. 14, 2017 /PRNewswire/ -- Array BioPharma (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to ..."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: 2017 By the Numbers : August 14, 2017",2017-08-14 18:36:44 +0000,http://finance.yahoo.com/r/24e0b183-700e-35c5-9199-ecb0af41bada/array-biopharma-inc-arry-us-earnings-analysis-2017-by-the-numbers-august-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Array BioPharma, Inc. reports financial results for the year ended June 30, 2017. We analyze the earnings along side the following peers of Array BioPharma, Inc. – Amgen Inc., Celgene Corporation, Albany Molecular Research, Inc., Astrazeneca PLC Sponsored ADR, Eli Lilly and Company, Cascadian Therapeutics Inc. and Novartis AG Sponsored ADR ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,Today's Research Reports on Trending Tickers: Array BioPharma Inc. and 22nd Century Group Inc.,2017-08-14 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000836.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 14, 2017 / U.S. markets battled geopolitical uncertainties Friday to close in the green, but still posted steep weekly losses. The Dow Jones Industrial Average gained ..."
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-08-12 12:01:41 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120141435.html?.tsrc=rss,"Index (PMI) data, output in the Healthcare sector is rising.  To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma Inc (ARRY) Files 10-K for the Fiscal Year Ended on June 30, 2017",2017-08-12 09:34:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M9oMvwaIsg0/array-biopharma-inc-arry-files-10-k-for-the-fiscal-year-ended-on-june-30-2017-cm831266,Array BioPharma Inc ARRY files its latest 10 K with SEC for the fiscal year ended on June 30 2017 Array BioPharma Inc is a biopharmaceutical company It is engaged in the discovery development and commercialization of targeted small molecule drugs to treat patients afflicted with
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-08-11 12:01:42 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120246156.html?.tsrc=rss,"Index (PMI) data, output in the Healthcare sector is rising.  To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : August 10, 2017",2017-08-10 12:23:08 +0000,http://finance.yahoo.com/r/69d5086d-343e-33d5-9bb7-6e1a540286ab/array-biopharma-inc-breached-its-50-day-moving-average-in-a-bullish-manner-arry-us-august-10-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Array BioPharma, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,IHS Markit Score Update: Drop in demand for ETFs holding Array Biopharma Inc is a negative sign for its shares,2017-08-10 12:01:44 +0000,https://finance.yahoo.com/news/ihs-markit-score-drop-demand-120144716.html?.tsrc=rss,"Index (PMI) data, output in the Healthcare sector is rising.  To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma reports 4Q loss,2017-08-10 01:30:44 +0000,https://finance.yahoo.com/news/array-biopharma-reports-4q-loss-102950863.html?.tsrc=rss,"The Boulder, Colorado-based company said it had a loss of 17 cents per share. The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research ..."
ARRY,ARRY:US,BBG000C52TW3,ARRY Makes Bullish Cross Above Critical Moving Average,2017-08-09 16:38:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zTP7izec7VU/arry-makes-bullish-cross-above-critical-moving-average-cm829637,In trading on Wednesday shares of Array BioPharma Inc Symbol ARRY crossed above their 200 day moving average of 8 78 changing hands as high as 8 88 per share Array BioPharma Inc shares are currently trading up about 11 4 on the day The chart below shows the one year performance of
ARRY,ARRY:US,BBG000C52TW3,See what the IHS Markit Score report has to say about Array Biopharma Inc.,2017-08-09 12:02:45 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120245517.html?.tsrc=rss,Array Biopharma Inc NASDAQ NMS:ARRY
ARRY,ARRY:US,BBG000C52TW3,Investor Network: Array BioPharma Inc. to Host Earnings Call,2017-08-09 10:10:00 +0000,https://finance.yahoo.com/news/investor-network-array-biopharma-inc-101000573.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 9, 2017 / Array BioPharma Inc. (NASDAQ: ARRY ) will be discussing their earnings results in their Q4 Earnings Call to be held on Wednesday, August 9, 2017 at 9:00 AM ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017,2017-08-09 10:00:00 +0000,https://finance.yahoo.com/news/array-biopharma-reports-financial-results-100000253.html?.tsrc=rss,"- New Drug Applications (NDAs) filed with FDA and Marketing Authorization Applications (MAAs) filed with EMA for binimetinib and encorafenib in BRAF-mutant advanced melanoma - - New license, development ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Q4 17 Earnings Conference Call At 9:00 AM ET,2017-08-09 08:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CdD0No4lShk/array-biopharma-q4-17-earnings-conference-call-at-900-am-et-20170809-00643,Array BioPharma Q4 17 Earnings Conference Call At 9:00 AM ET
ARRY,ARRY:US,BBG000C52TW3,Here&apos;s Why Array BioPharma Inc. Fell 13.7% in July,2017-08-07 20:19:00 +0000,http://finance.yahoo.com/r/dd5d3a3b-8e7c-3ff9-95b0-18659265b11b/heres-why-array-biopharma-inc-fell-137-in-may.aspx?yptr=yahoo&.tsrc=rss,"Despite sharing upbeat news, shares of the clinical-stage biotech fell by double-digits."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. – Value Analysis (NASDAQ:ARRY) : August 5, 2017",2017-08-05 00:15:57 +0000,http://finance.yahoo.com/r/72d3de8b-dfac-34f6-96d8-e42926f83ff0/array-biopharma-inc-value-analysis-nasdaqarry-august-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Array BioPharma, Inc. a score of 22. Our analysis is based on comparing Array BioPharma, Inc. with the following peers – Amgen Inc., Celgene Corporation, Albany Molecular Research, Inc., Astrazeneca PLC Sponsored ADR, Eli Lilly and Company, Onconova Therapeutics Inc., Cascadian Therapeutics Inc. and Novartis AG Sponsored ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2017 On August 9, 2017",2017-08-03 15:49:00 +0000,https://finance.yahoo.com/news/array-biopharma-report-financial-results-154900618.html?.tsrc=rss,"BOULDER, Colo. , Aug. 3, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the fourth quarter and full year of fiscal 2017 and hold a conference call to discuss ..."
ARRY,ARRY:US,BBG000C52TW3,Mid-Morning Market Update: Markets Mostly Lower; Halliburton Profit Tops Estimates,2017-07-24 15:37:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/yuTN9h-XMn4/mid-morning-market-update-markets-mostly-lower-halliburton-profit-tops-estimates-cm820244,Following the market opening Monday the Dow traded down 0 21 percent to 21 534 81 while the NASDAQ climbed 0 06 percent to 6 391 25 The S amp P also fell dropping 0 15 percent to 2 468 87 Leading and Lagging Sectors Financial shares climbed by 0 20 percent in the US market
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : July 24, 2017",2017-07-24 13:32:19 +0000,http://finance.yahoo.com/r/4a42215b-0a98-3978-9d51-f47bcbabf184/array-biopharma-inc-breached-its-50-day-moving-average-in-a-bearish-manner-arry-us-july-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Array BioPharma, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,New Strong Sell Stocks for July 20th,2017-07-20 17:05:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FTR-c2rPvto/new-strong-sell-stocks-for-july-20th-cm818778,Here are 5 stocks added to the Zacks Rank 5 Strong Sell List today Akamai Technologies Inc AKAM is a major cloud services 160 provider The Zacks Consensus Estimate for its current year earnings has been revised 1 7 downward over the last 30 days Shire plc SHPG is a
ARRY,ARRY:US,BBG000C52TW3,New Strong Sell Stocks for July 20th,2017-07-20 15:08:03 +0000,https://finance.yahoo.com/news/strong-sell-stocks-july-20th-150803199.html?.tsrc=rss,Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
ARRY,ARRY:US,BBG000C52TW3,Colorado biotech makes deal with industry giant,2017-07-18 16:03:51 +0000,http://finance.yahoo.com/r/b37df776-d08b-3e49-8c42-a66e580a1d93/boulder-biotech-makes-deal-with-industry-giant.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"A Boulder biotech said it's made a deal with an industry giant to develop drugs for autoimmune disorders.  Array BioPharma Inc. (ARRY) said it's made a deal with giant Amgen Inc. (AMGN) of Thousand Oaks, California to take advantage of Array's inflammatory disease discoveries.  ""The identification of this novel target, along with our team's deep experience in kinase inhibitor chemistry, gives us confidence that our efforts will result in a drug which will address a significant unmet medical need for patients with inflammatory disease,"" said Nicholas Saccomano, chief scientific officer at Array, in a statement."
ARRY,ARRY:US,BBG000C52TW3,Amgen And Array BioPharma Announce Preclinical License And Collaboration Agreement In Inflammation,2017-07-18 12:00:00 +0000,https://finance.yahoo.com/news/amgen-array-biopharma-announce-preclinical-120000900.html?.tsrc=rss,"THOUSAND OAKS, Calif. and BOULDER, Colo., July 18, 2017 /PRNewswire/ -- Amgen (AMGN) and Array BioPharma (ARRY) today announced a collaboration agreement for the discovery and development of novel drugs for autoimmune disorders.  ""We are pleased to enter this collaboration with Array that builds on our continued focus in inflammation, one of Amgen's key strategic areas of interest,"" said Flavius Martin, M.D., vice president of Research, Inflammation and Oncology at Amgen."
ARRY,ARRY:US,BBG000C52TW3,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Array BioPharma Inc.",2017-07-14 14:04:00 +0000,https://finance.yahoo.com/news/shareholder-alert-levi-korsinsky-llp-140400890.html?.tsrc=rss,Levi & Korsinsky announces it has commenced an investigation of Array BioPharma Inc. concerning possible violations of federal securities laws.
ARRY,ARRY:US,BBG000C52TW3,"ETFs with exposure to Array BioPharma, Inc. : July 12, 2017",2017-07-12 18:12:30 +0000,http://finance.yahoo.com/r/d30582fb-8026-3d4e-9edd-e1e3f8aa208b/etfs-with-exposure-to-array-biopharma-inc-july-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,Implied Volatility Surging for Array BioPharma Inc. (ARRY) Stock Options,2017-07-10 14:51:14 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H56wyZ0d_ms/implied-volatility-surging-for-array-biopharma-inc-arry-stock-options-cm813736,Investors in Array BioPharma Inc ARRY need to pay close attention to the stock based on moves in the options market lately That is because the Jul 21 st 2017 18 00 Cal had some of the highest implied volatility of all equity options today What is Implied Volatility Implied
ARRY,ARRY:US,BBG000C52TW3,Implied Volatility Surging for Array BioPharma Inc. (ARRY) Stock Options,2017-07-10 12:37:12 +0000,https://finance.yahoo.com/news/implied-volatility-surging-array-biopharma-123712492.html?.tsrc=rss,Implied Volatility Surging for Array BioPharma Inc. (ARRY) Stock makes it lucrative to Option traders.
ARRY,ARRY:US,BBG000C52TW3,Array (ARRY) Submits NDA for Melanoma Combination Therapy,2017-07-06 23:43:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HpVZ7guwg2E/array-arry-submits-nda-for-melanoma-combination-therapy-cm812759,Array BioPharma ARRY announced that it has submitted two new drug applications NDAs to FDA seeking approval for the combination of binimetinib and encorafenib to treat patients with BRAF mutant advanced unresectable or metastatic melanoma Notably both binimetinib and encorafenib
ARRY,ARRY:US,BBG000C52TW3,Array (ARRY) Submits NDA for Melanoma Combination Therapy,2017-07-06 22:02:10 +0000,https://finance.yahoo.com/news/array-arry-submits-nda-melanoma-220210762.html?.tsrc=rss,"Array BioPharma (ARRY) announced that it has submitted two new drug applications (NDAs) to FDA, seeking approval for the combination of binimetinib and encorafenib to treat patients with BRAF-mutant advanced, unresectable or metastatic melanoma."
ARRY,ARRY:US,BBG000C52TW3,"ARRY Working Its Way, Be All Ears For Auris, BGNE Inks Deal With CELG",2017-07-06 04:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/S1i7ltsXB9E/arry-working-its-way-be-all-ears-for-auris-bgne-inks-deal-with-celg-20170706-00114,"ARRY Working Its Way, Be All Ears For Auris, BGNE Inks Deal With CELG"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma’s New FDA Submissions Enough to Excite Investors?,2017-07-05 13:50:04 +0000,https://finance.yahoo.com/news/array-biopharma-fda-submissions-enough-135004927.html?.tsrc=rss,Array BioPharma has announced the submission to the FDA of two New Drug Applications to support the use of the combination of binimetinib and encorafenib for the treatment of patients with melanoma.
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Submits New Drug Applications To FDA For Binimetinib And Encorafenib In Advanced Melanoma,2017-07-05 12:00:00 +0000,https://finance.yahoo.com/news/array-biopharma-submits-drug-applications-120000540.html?.tsrc=rss,"BOULDER, Colo. , July 5, 2017 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) to support ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Submits NDAs For Binimetinib & Encorafenib In Advanced Melanoma,2017-07-05 08:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QVuD62Q0_yA/array-biopharma-submits-ndas-for-binimetinib--encorafenib-in-advanced-melanoma-20170705-00417,Array BioPharma Submits NDAs For Binimetinib & Encorafenib In Advanced Melanoma
ARRY,ARRY:US,BBG000C52TW3,"ETFs with exposure to Array BioPharma, Inc. : June 27, 2017",2017-06-27 18:54:09 +0000,http://finance.yahoo.com/r/92010489-4abd-364d-833d-c75e90cd04e8/etfs-with-exposure-to-array-biopharma-inc-june-27-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,"Commit To Buy Array BioPharma At $4, Earn 13.8% Using Options",2017-06-27 16:49:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EXtZ7i0XxAs/commit-to-buy-array-biopharma-at-4-earn-138-using-options-cm808869,Investors considering a purchase of Array BioPharma Inc Symbol ARRY shares but tentative about paying the going market price of 8 91 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
ARRY,ARRY:US,BBG000C52TW3,Are Options Traders Betting on a Big Move in Array BioPharma (ARRY) Stock?,2017-06-23 13:54:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ix51u9X75jM/are-options-traders-betting-on-a-big-move-in-array-biopharma-arry-stock-cm807369,Investors in Array BioPharma Inc ARRY need to pay close attention to the stock based on moves in the options market lately That is because the July 21 2017 18 Call had some of the highest implied volatility of all equity options today What is Implied Volatility Implied
ARRY,ARRY:US,BBG000C52TW3,Are Options Traders Betting on a Big Move in Array BioPharma (ARRY) Stock?,2017-06-23 12:32:12 +0000,https://finance.yahoo.com/news/options-traders-betting-big-move-123212711.html?.tsrc=rss,Investors in Array BioPharma Inc. (ARRY) need to pay close attention to the stock based on moves in the options market lately.
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : June 21, 2017",2017-06-21 12:06:44 +0000,http://finance.yahoo.com/r/bce97376-1d26-3bbf-9a16-eebb633eda4f/array-biopharma-inc-breached-its-50-day-moving-average-in-a-bullish-manner-arry-us-june-21-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Array BioPharma, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,ARRY Crosses Above Key Moving Average Level,2017-06-20 22:19:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uue-YwUUv_U/arry-crosses-above-key-moving-average-level-cm805961,In trading on Tuesday shares of Array BioPharma Inc Symbol ARRY crossed above their 200 day moving average of 8 21 changing hands as high as 8 66 per share Array BioPharma Inc shares are currently trading up about 8 on the day The chart below shows the one year performance of
ARRY,ARRY:US,BBG000C52TW3,"ETFs with exposure to Array BioPharma, Inc. : June 16, 2017",2017-06-16 19:24:16 +0000,http://finance.yahoo.com/r/99db1063-1c29-3828-a148-20eb79ade140/etfs-with-exposure-to-array-biopharma-inc-june-16-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q3, 2017 By the Numbers : June 14, 2017",2017-06-14 14:01:34 +0000,http://finance.yahoo.com/r/c73d04d5-86c3-3de8-bd95-7cb9bb3a6ca0/array-biopharma-inc-arry-us-earnings-analysis-q3-2017-by-the-numbers-june-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Array BioPharma, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Array BioPharma, Inc. – Amgen Inc., Celgene Corporation, Albany Molecular Research, Inc., Astrazeneca PLC Sponsored ADR, Eli Lilly and Company, Onconova Therapeutics Inc., Cascadian Therapeutics Inc. and Novartis ... Read more
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma To Present At The Goldman Sachs Conference; Webcast At 1:00 PM,2017-06-13 12:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5IGd6xattCk/array-biopharma-to-present-at-the-goldman-sachs-conference-webcast-at-100-pm-20170613-00937,Array Biopharma To Present At The Goldman Sachs Conference; Webcast At 1:00 PM
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Inc. Sank 13.5% in May,2017-06-05 23:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/F7mJU9O6csI/why-array-biopharma-inc-sank-135-in-may-cm799029,What happened Shares of Array BioPharma NASDAQ ARRY a clinical stage biotech focused on cancer dropped 13 in May according to data from S amp P Global Market Intelligence The big drop has this Fool scratching his head given all the positive announcements made during
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Inc. Sank 13.5% in May,2017-06-05 21:49:00 +0000,http://finance.yahoo.com/r/4d781446-e781-3df3-b0eb-53c0e35d5ec4/why-array-biopharma-inc-sank-135-in-may.aspx?yptr=yahoo&.tsrc=rss,It was an eventful month for the clinical-stage biotech. Here&apos;s a look at the key headlines that drove the stock&apos;s performance.
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma To Present At The Goldman Sachs 38th Annual Global Healthcare Conference,2017-06-01 14:00:00 +0000,https://finance.yahoo.com/news/array-biopharma-present-goldman-sachs-140000065.html?.tsrc=rss,"BOULDER, Colo., June 1, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Operating Officer, Andy Robbins, will present at the Goldman Sachs 38th Annual Global Healthcare ..."
ARRY,ARRY:US,BBG000C52TW3,"Blog Coverage: Array BioPharma and Bristol-Myers Squibb Partner to Investigate Combinations of Binimetinib, Opdivo, and Yervoy in Colorectal Cancer Patients",2017-06-01 12:15:00 +0000,https://finance.yahoo.com/news/blog-coverage-array-biopharma-bristol-121500346.html?.tsrc=rss,"LONDON, UK / ACCESSWIRE / June 1, 2017 / Active Wall St. blog coverage looks at the headline from Array BioPharma Inc. (NASDAQ: ARRY ) and Bristol-Myers Squibb Co. (NYSE: BMY ) as both companies announced ..."
ARRY,ARRY:US,BBG000C52TW3,Bristol-Myers Partners Array to Investigate Cancer Candidate,2017-05-31 17:33:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_wnmpJUOHDI/bristol-myers-partners-array-to-investigate-cancer-candidate-cm796955,Bristol Myers Squibb Company BMY and Array BioPharma ARRY entered into a clinical research collaboration to investigate the safety tolerability and efficacy of Array s binimetinib in combination with Bristol Myers Squibb s Opdivo nivolumab and Opdivo Yervoy ipilimumab regimen 160
ARRY,ARRY:US,BBG000C52TW3,Bristol-Myers Partners Array to Investigate Cancer Candidate,2017-05-31 15:13:03 +0000,https://finance.yahoo.com/news/bristol-myers-partners-array-investigate-151303590.html?.tsrc=rss,"Bristol-Myers Squibb Company (BMY) and Array BioPharma (ARRY) entered into a clinical research collaboration to investigate the safety, tolerability and efficacy of Array&apos;s binimetinib in combination with the former&apos;s Opdivo and Opdivo + Yervoy regimen."
ARRY,ARRY:US,BBG000C52TW3,"Biotech Movers: Akari, Array, Amicus",2017-05-31 13:54:00 +0000,http://finance.yahoo.com/r/2458acde-779b-3142-8501-d68a8599e02d/biotech-movers-akari-array-amicus.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Akari Therapeutics, Array BioPharma and Amicus Therapeutics were among the biotech movers in premarket trading on Wednesday."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma And Ono Pharmaceutical Co., Ltd. Announce A License, Development And Commercialization Partnership For Two Novel Oncology Compounds, Binimetinib And Encorafenib",2017-05-31 07:00:00 +0000,https://finance.yahoo.com/news/array-biopharma-ono-pharmaceutical-co-070000420.html?.tsrc=rss,"BOULDER, Colo. and OSAKA, Japan, May 31, 2017 /PRNewswire/ -- Array BioPharma Inc. (ARRY) and Ono Pharmaceutical Co., Ltd. (""Ono"") today announced a license, development and commercialization partnership for Array's late-stage novel oncology compounds, binimetinib and encorafenib.  As a result of this agreement, Ono will receive rights to develop and commercialize binimetinib and encorafenib in Japan and South Korea.  Binimetinib, a MEK inhibitor, and encorafenib, a BRAF inhibitor, are currently in two global Phase 3 trials, for the treatment of patients with BRAF-mutant melanoma (COLUMBUS) and BRAF-mutant colorectal cancer (BEACON CRC)."
ARRY,ARRY:US,BBG000C52TW3,Bristol-Myers Hookup Boosts Array BioPharma,2017-05-30 22:20:00 +0000,http://finance.yahoo.com/r/108e2294-4a2d-3e8e-bbe1-cea652cc1a4e/bristol-myers-hookup-boosts-array-biopharma.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Arrary reacquired MEK inhibitor in 2015 as part of FTC settlement with Novartis.
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Bristol-Myers Squibb to collaborate on cancer drug research",2017-05-30 20:14:25 +0000,http://finance.yahoo.com/r/eafc7427-b9a0-372f-a20d-db941a725516/array-biopharma-bristol-myers-squibb-to.html?ana=yahoo&yptr=yahoo&.tsrc=rss,"Array BioPharma and pharmaceutical giant Bristol-Myers Squibb will test the effectiveness of Array’s drug binimetinib in combination with a Bristol-Myers’ immunotherapy drug as a treatment for some kinds of colorectal cancer.  The research partnership, announced Tuesday, is the second announced this month by Boulder-based Array BioPharma Inc. (ARRY) for testing binimetinib as part of a treatment for colorectal cancer cases with metastatic tumors.  The new pact with New York City-based Bristol-Myers Squibb will have both companies supporting early-phase clinical trials testing binimetinib in combination with Bristol-Myers cancer drug Opdivo and added as a third drug used in combination with Opdivo and Yervoy."
ARRY,ARRY:US,BBG000C52TW3,Biotech Movers: Array Shares Rise on Bristol-Myers Collaboration,2017-05-30 13:29:00 +0000,http://finance.yahoo.com/r/b29d834b-7687-35ad-88dd-539b3df20949/biotech-movers-array-shares-rise-on-bristol-myers-collaboration.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Array BioPharma, Advaxis, Merrimack Pharmaceuticals and Insys Therapeutics were among the biotech stock movers in premarket trading on Tuesday."
ARRY,ARRY:US,BBG000C52TW3,"Pre-Market Most Active for May 30, 2017 :  NOK, ORAN, NVO, ATW, NVDA, F, NE, PSDV, TVIX, ARRY, CCN, VOD",2017-05-30 13:00:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-nHGGOUze6w/pre-market-most-active-for-may-30-2017-nok-oran-nvo-atw-nvda-f-ne-psdv-tvix-arry-ccn-vod-cm796024,The NASDAQ 100 Pre Market Indicator is down 2 67 to 5 785 69 The total Pre Market volume is currently 5 605 637 shares traded The following are the most active stocks for the pre market session Nokia Corporation NOK is 0 1 at 6 28 with 1 557 823 shares traded
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration,2017-05-30 10:59:00 +0000,https://finance.yahoo.com/news/array-biopharma-bristol-myers-squibb-105900638.html?.tsrc=rss,"BOULDER, Colo. and NEW YORK, May 30, 2017 /PRNewswire/ --  Array BioPharma (Nasdaq: ARRY) and Bristol-Myers Squibb Company (NYSE:BMY) today announced the companies have entered into a clinical research ..."
ARRY,ARRY:US,BBG000C52TW3,How Two Biotechs Fell On Cancer Partnerships With Bristol-Myers,2017-05-30 09:17:00 +0000,http://finance.yahoo.com/r/8f0075c4-8c0e-3b53-abc6-099ece5296bc/how-these-biotechs-split-on-cancer-partnerships-with-bristol-myers?src=A00220&yptr=yahoo&.tsrc=rss,Array and Advaxis shares tumbled more than 3% in action Tuesday after the firms announced partnerships with Bristol.
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Bristol-Myers Squibb Announce Strategic Collaboration",2017-05-30 07:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/AsazgK3NuVg/array-biopharma-bristolmyers-squibb-announce-strategic-collaboration-20170530-00298,"Array BioPharma, Bristol-Myers Squibb Announce Strategic Collaboration"
ARRY,ARRY:US,BBG000C52TW3,"After Hours Most Active for May 18, 2017 :  ETE, EPD, BX, BAC, MPLX, ODP, NGL, QQQ, FB, AMAT, INTC, ARRY",2017-05-18 21:01:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/npzLtdakn3k/after-hours-most-active-for-may-18-2017-ete-epd-bx-bac-mplx-odp-ngl-qqq-fb-amat-intc-arry-cm791565,The NASDAQ 100 After Hours Indicator is up 4 95 to 5 631 26 The total After hours volume is currently 49 368 094 shares traded The following are the most active stocks for the after hours session Energy Transfer Equity L P ETE is 0 0256 at 18 00 with 5 273
ARRY,ARRY:US,BBG000C52TW3,Blog Coverage: Mirna Announced Reverse Merger Agreement,2017-05-17 12:15:00 +0000,https://finance.yahoo.com/news/blog-coverage-mirna-announced-reverse-121500772.html?.tsrc=rss,"Upcoming AWS Coverage on Array BioPharma Post-Earnings Results LONDON, UK / ACCESSWIRE / May 17, 2017 / Active Wall St. blog coverage looks at the headline from Mirna Therapeutics Inc. (NASDAQ: MIRN ) ..."
ARRY,ARRY:US,BBG000C52TW3,Edited Transcript of ARRY earnings conference call or presentation 10-May-17 1:00pm GMT,2017-05-16 21:30:59 +0000,https://finance.yahoo.com/news/edited-transcript-arry-earnings-conference-123613074.html?.tsrc=rss,Q3 2017 Array Biopharma Inc Earnings Call
ARRY,ARRY:US,BBG000C52TW3,Today's Research Reports on Stocks to Watch: Array Biopharma and Verastem,2017-05-11 12:00:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-120000278.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 11, 2017 / U.S. markets were relatively quiet Wednesday as investors analyzed the latest batch of corporate earnings. Additionally, President Trump on Wednesday announced ..."
ARRY,ARRY:US,BBG000C52TW3,"Gainers & Losers Of May 10: CUR, TEAR, PRTO, CXRX, DERM...",2017-05-10 22:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VoFUIUbQ_DM/gainers--losers-of-may-10-cur-tear-prto-cxrx-derm-20170510-01922,"Gainers & Losers Of May 10: CUR, TEAR, PRTO, CXRX, DERM..."
ARRY,ARRY:US,BBG000C52TW3,"Health Care Sector Update for 05/10/2017: ARRY,MTBC,CXRX",2017-05-10 20:40:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8xEN1ropxkY/health-care-sector-update-for-05102017-arrymtbccxrx-cm787497,Top Health Care StocksTop Health Care Stocks JNJ 0 32 JNJ 0 32 PFE 0 09 PFE 0 09 ABT 0 41 ABT 0 41 MRK 0 98 MRK 0 98 AMGN 1 68 AMGN 1 68 Health care stocks were mostly lower today with shares of health care companies in the S amp P 500 losing less than 0 3 in value although
ARRY,ARRY:US,BBG000C52TW3,Here's Why the Market's Overlooking Array Biopharma Inc.'s Earnings Miss Today,2017-05-10 19:04:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/logbT26aSdQ/heres-why-the-markets-overlooking-array-biopharma-incs-earnings-miss-today-cm787408,What happened Shares of Array Biopharma Inc NASDAQ ARRY a biotech with several new drug candidates in late development stages is surging after the release of clinical trial results along with an earnings report Despite slight misses on the top and bottom lines at 11 a m
ARRY,ARRY:US,BBG000C52TW3,"Array Biopharma Sees Positive Study Results From COLUMBUS Phase 2, But Commercialization May Prove Daunting",2017-05-10 17:12:13 +0000,http://finance.yahoo.com/news/array-biopharma-sees-positive-study-171213701.html?.tsrc=rss,"Following Array Biopharma Inc (NASDAQ: ARRY ) reporting positive top line results from part 2 of a late-stage study of its combo treatment candidate for metastatic and BRAF-mutant melanoma, Leerink thinks ..."
ARRY,ARRY:US,BBG000C52TW3,Mid-Day Market Update: Crude Oil Down 3%; Proteon Therapeutics Shares Spike Higher,2017-05-10 17:10:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A6v_hCvbD4U/mid-day-market-update-crude-oil-down-3-proteon-therapeutics-shares-spike-higher-cm787357,Midway through trading Wednesday the Dow traded down 0 08 percent to 20 959 85 while the NASDAQ declined 0 12 percent to 6 113 15 The S amp P also rose gaining 0 02 percent to 2 397 31 Leading and Lagging Sectors Energy sector was the top gainer in the US market on Wednesday
ARRY,ARRY:US,BBG000C52TW3,Here&apos;s Why the Market&apos;s Overlooking Array Biopharma Inc.&apos;s Earnings Miss Today,2017-05-10 17:00:00 +0000,http://finance.yahoo.com/r/a629a994-d16f-304d-a8a2-5260b5ecf8af/heres-why-the-markets-overlooking-array-biopharma.aspx?yptr=yahoo&.tsrc=rss,"Array Biopharma&apos;s financial results get the back seat today, while clinical-trial results ride shotgun."
ARRY,ARRY:US,BBG000C52TW3,Mid-Morning Market Update: Markets Open Lower; NVIDIA Beats Q1 Estimates,2017-05-10 15:40:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MgcyHOG8EGI/mid-morning-market-update-markets-open-lower-nvidia-beats-q1-estimates-cm787273,Following the market opening Wednesday the Dow traded down 0 21 percent to 20 931 08 while the NASDAQ declined 0 08 percent to 6 115 92 The S amp P also fell dropping 0 04 percent to 2 395 87 Leading and Lagging Sectors Energy sector was the top gainer in the US market
ARRY,ARRY:US,BBG000C52TW3,"Pre-Market Most Active for May 10, 2017 :  WSTC, NVDA, AUO, YELP, MYL, ANF, MT, OPK, SKX, AAPL, INN, ARRY",2017-05-10 13:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Uo9lhulF7D4/pre-market-most-active-for-may-10-2017-wstc-nvda-auo-yelp-myl-anf-mt-opk-skx-aapl-inn-arry-cm787015,The NASDAQ 100 Pre Market Indicator is up 2 74 to 5 681 05 The total Pre Market volume is currently 9 197 629 shares traded The following are the most active stocks for the pre market session West Corporation WSTC is 0 98 at 23 13 with 4 579 964 shares traded
ARRY,ARRY:US,BBG000C52TW3,Investor Network: Array BioPharma Inc. to Host Earnings Call,2017-05-10 12:30:00 +0000,http://finance.yahoo.com/news/investor-network-array-biopharma-inc-123000740.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / May 10, 2017 / Array BioPharma Inc. (NASDAQ: ARRY ) will be discussing their earnings results in their Q3 Earnings Call to be held May 10, 2017 at 9:00 AM Eastern Time. To listen ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma reports 3Q loss,2017-05-10 12:14:30 +0000,http://finance.yahoo.com/news/array-biopharma-reports-3q-loss-121430223.html?.tsrc=rss,"The Boulder, Colorado-based company said it had a loss of 21 cents per share. The results did not meet Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2017,2017-05-10 12:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-reports-financial-results-120000686.html?.tsrc=rss,"BOULDER, Colo., May 10, 2017 /PRNewswire/ -- COLUMBUS / BRAF-mutant melanoma Part 2 demonstrates positive results and New Drug Application (NDA) filing on track for June or July 2017 New Binimetinib / ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRY Hits Trial Goals, DEPO Falls On Q1 Results, SAGE Awaits Data In Q3",2017-05-10 01:58:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Zfgxi_f0tJk/arry-hits-trial-goals-depo-falls-on-q1-results-sage-awaits-data-in-q3-20170510-00077,"ARRY Hits Trial Goals, DEPO Falls On Q1 Results, SAGE Awaits Data In Q3"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Positive Top-Line Results from Part 2 of the Phase 3 COLUMBUS Study of Binimetinib and Encorafenib for BRAF-Mutant Melanoma,2017-05-09 20:01:00 +0000,http://finance.yahoo.com/news/array-biopharma-announces-positive-top-200100947.html?.tsrc=rss,"BOULDER, Colo., May 9, 2017 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) today announced top-line results from Part 2 of the Phase 3 COLUMBUS study evaluating binimetinib, a MEK inhibitor, and encorafenib, ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Strategic Collaboration with Merck,2017-05-08 12:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-announces-strategic-collaboration-120000006.html?.tsrc=rss,"BOULDER, Colo., May 8, 2017 /PRNewswire/ -- Array BioPharma Inc. (ARRY) announced today that it has entered into a clinical trial collaboration agreement with Merck (known as MSD outside the United States and Canada) to investigate the safety and efficacy of Array's MEK inhibitor, binimetinib, with Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in metastatic colorectal cancer patients with microsatellite stable tumors (MSS CRC)."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Collaborate With Merck To Study Binimetinib & Keytruda,2017-05-08 08:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KoPaFWPCj3Y/array-biopharma-to-collaborate-with-merck-to-study-binimetinib--keytruda-20170508-00583,Array BioPharma To Collaborate With Merck To Study Binimetinib & Keytruda
ARRY,ARRY:US,BBG000C52TW3,"Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma",2017-05-03 14:09:00 +0000,http://finance.yahoo.com/r/d9fdad7d-97e7-373c-ab5a-b92f887243b5/biotech-movers-myriad-genetics-spectrum-pharmaceuticals-array-biopharma.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Myriad Genetics, Spectrum Pharmaceuticals and Array BioPharma were among the biotech stock movers in early trading on Wednesday."
ARRY,ARRY:US,BBG000C52TW3,"Array Biopharma To Report Financial Results For The Third Quarter Of Fiscal 2017 On May 10, 2017",2017-05-03 12:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-report-financial-results-120000693.html?.tsrc=rss,"BOULDER, Colo., May 3, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq:  ARRY) will report financial results for the third quarter of fiscal 2017 and hold a conference call to discuss those results on ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Breaks Below 200-Day Moving Average - Notable for ARRY,2017-05-02 22:26:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rSCb-I7lOiE/array-biopharma-breaks-below-200-day-moving-average-notable-for-arry-cm783072,In trading on Tuesday shares of Array BioPharma Inc Symbol ARRY crossed below their 200 day moving average of 7 49 changing hands as low as 7 08 per share Array BioPharma Inc shares are currently trading down about 16 on the day The chart below shows the one year performance of
ARRY,ARRY:US,BBG000C52TW3,"After Hours Most Active for May 2, 2017 :  TWLO, AAPL, V, GE, OCLR, BMY, NBL, INTC, MSFT, SYF, ARRY, MU",2017-05-02 20:56:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Z10_laMuoEQ/after-hours-most-active-for-may-2-2017-twlo-aapl-v-ge-oclr-bmy-nbl-intc-msft-syf-arry-mu-cm783059,The NASDAQ 100 After Hours Indicator is down 14 98 to 5 629 09 The total After hours volume is currently 41 884 707 shares traded The following are the most active stocks for the after hours session Twilio Inc TWLO is 10 06 at 23 88 with 3 312 317 shares
ARRY,ARRY:US,BBG000C52TW3,Shalini Sharp Joins Array BioPharma Board of Directors,2017-04-27 18:00:00 +0000,http://finance.yahoo.com/news/shalini-sharp-joins-array-biopharma-180000236.html?.tsrc=rss,"BOULDER, Colo., April 27, 2017 /PRNewswire/ -- Array BioPharma Inc. (ARRY) today announced that Shalini Sharp, Chief Financial Officer and Executive Vice President of Ultragenyx Pharmaceutical Inc., joined the company's Board of Directors, effective April 27, 2017.  Ms. Sharp has served as Chief Financial Officer of Ultragenyx, a biopharmaceutical company focused on rare diseases, since 2012, where she is responsible for leading the corporate finance, strategy, and information technology functions and is a member of the company's executive leadership team.  Ms. Sharp brings nearly 20 years of experience in the life sciences industry."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Enters Oversold Territory (ARRY),2017-04-21 22:02:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6dS3S5rJGn4/array-biopharma-enters-oversold-territory-arry-cm777362,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ARRY,ARRY:US,BBG000C52TW3,"If You Don't Buy These 5 Stocks Before Their Looming Breakout, It's Your Loss",2017-04-20 22:22:00 +0000,http://finance.yahoo.com/r/244447e3-f947-3080-ad66-4a11cd405378/trading-5-hot-charts-set-to-break-out-soon-for-profit.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's how to potentially rake in some fat profits off a number of hot breakout setups.
ARRY,ARRY:US,BBG000C52TW3,"After Hours Most Active for Apr 19, 2017 :  GE, EBAY, LC, PFE, SWNC, GIMO, QCOM, WLL, ARRY, YHOO, MSFT, CMCSA",2017-04-19 21:02:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qaUNlOpPGII/after-hours-most-active-for-apr-19-2017-ge-ebay-lc-pfe-swnc-gimo-qcom-wll-arry-yhoo-msft-cmcsa-cm776117,The NASDAQ 100 After Hours Indicator is up 2 62 to 5 402 26 The total After hours volume is currently 28 682 345 shares traded The following are the most active stocks for the after hours session General Electric Company GE is unchanged at 30 00 with 1 569 108
ARRY,ARRY:US,BBG000C52TW3,Today's Research Reports on Biotech Stocks to Watch: Array Biopharma and ImmunoGen,2017-04-17 11:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-biotech-stocks-113000670.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / April 17, 2017 / The Biotech Industry has continued to provide solid gains for investors in 2017, despite all the negative attention the industry has received due to drug pricing ..."
ARRY,ARRY:US,BBG000C52TW3,Do Options Traders Know Something About Array BioPharma (ARRY) Stock We Don't?,2017-04-07 14:58:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vtiyw0ij8E0/do-options-traders-know-something-about-array-biopharma-arry-stock-we-dont-cm771286,Investors in Array BioPharma Inc ARRY need to pay close attention to the stock based on moves in the options market lately That is because the April 21 st 2017 13 Put had some of the highest implied volatility of all equity options today What is Implied Volatility Implied
ARRY,ARRY:US,BBG000C52TW3,Do Options Traders Know Something About Array BioPharma (ARRY) Stock We Don&apos;t?,2017-04-07 12:48:12 +0000,http://finance.yahoo.com/news/options-traders-know-something-array-124812386.html?.tsrc=rss,Investors in Array BioPharma Inc. (ARRY) need to pay close attention to the stock based on moves in the options market lately.
ARRY,ARRY:US,BBG000C52TW3,Oversold Conditions For Array BioPharma (ARRY),2017-03-29 18:00:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WLHPOoTr4xA/oversold-conditions-for-array-biopharma-arry-cm767355,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma's NDA for Cancer Drug Withdrawn; Shares Down,2017-03-22 16:10:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/WqNeqUhC1IU/array-biopharmas-nda-for-cancer-drug-withdrawn-shares-down-cm764107,Shares of Array BioPharma Inc ARRY slipped 2 30 after the company announced that it has withdrawn its new drug application NDA for its pipeline candidate binimetinib from the FDA s Division of Oncology Products 2 The candidate was being evaluated as a monotherapy for the treatment
ARRY,ARRY:US,BBG000C52TW3,Will Array Biopharma's Melanoma Drugs Keep the Stock Soaring?,2017-03-22 15:08:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bTcOXFQCIcQ/will-array-biopharmas-melanoma-drugs-keep-the-stock-soaring-cm764036,Success in trials of new drugs for metastatic melanoma propelled the stock of Array Biopharma NASDAQ ARRY 115 in 2016 However after a string of successes Array hit a setback earlier this week It withdrew its first ever new drug application Fortunately there s more to
ARRY,ARRY:US,BBG000C52TW3,"Biotech Stock Roundup: Amgen Down on Repatha Data, Nektar Surges on Pain Results",2017-03-22 14:09:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/veBMJx2G_Gg/biotech-stock-roundup-amgen-down-on-repatha-data-nektar-surges-on-pain-results-cm764070,Biotech stocks were hit by the release of the Budget Blueprint for 2018 which could require companies to shell out higher fees for regulatory reviews Moreover the budget proposes a reduction of 5 8 billion in the National Institutes of Health s NIH spending Other key updates include Amgen
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma's NDA for Cancer Drug Withdrawn; Shares Down,2017-03-22 13:58:01 +0000,http://finance.yahoo.com/news/array-biopharmas-nda-cancer-drug-135801044.html?.tsrc=rss,"Shares of Array BioPharma Inc. (ARRY) slipped 2.30% after the company announced that it has withdrawn its new drug application (NDA) for its pipeline candidate, binimetinib, from the FDA's Division of Oncology Products 2."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma's NDA for Cancer Drug Withdrawn; Shares Down,2017-03-22 13:58:01 +0000,http://finance.yahoo.com/news/array-biopharmas-nda-cancer-drug-135801044.html,Array BioPharma's NDA for Cancer Drug Withdrawn; Shares Down
ARRY,ARRY:US,BBG000C52TW3,Will Array Biopharma's Melanoma Drugs Keep the Stock Soaring?,2017-03-22 13:42:00 +0000,https://www.fool.com/investing/2017/03/22/will-array-biopharmas-melanoma-drugs-keep-the-stoc.aspx,Will Array Biopharma's Melanoma Drugs Keep the Stock Soaring?
ARRY,ARRY:US,BBG000C52TW3,Will Array Biopharma's Melanoma Drugs Keep the Stock Soaring?,2017-03-22 13:42:00 +0000,http://finance.yahoo.com/r/47abb204-746a-3667-abce-1318aca182e9/will-array-biopharmas-melanoma-drugs-keep-the-stoc.aspx?yptr=yahoo&.tsrc=rss,"A setback this week illustrates the challenges, but Array still has plenty of opportunity."
ARRY,ARRY:US,BBG000C52TW3,"After Hours Most Active for Mar 20, 2017 :  LYG, BAC, GM, MTG, MPC, HPQ, INTC, AAPL, CSCO, FOLD, MSFT, ARRY",2017-03-20 20:56:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oh9nw22e0l4/after-hours-most-active-for-mar-20-2017-lyg-bac-gm-mtg-mpc-hpq-intc-aapl-csco-fold-msft-arry-cm763155,The NASDAQ 100 After Hours Indicator is down 25 to 5 413 06 The total After hours volume is currently 34 505 353 shares traded The following are the most active stocks for the after hours session Lloyds Banking Group Plc LYG is 0 01 at 3 49 with 10 780 719
ARRY,ARRY:US,BBG000C52TW3,"How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More",2017-03-20 18:03:00 +0000,http://finance.yahoo.com/r/d0798c90-f870-3f75-aed5-62416f0bacc4/how-to-trade-monday-s-most-active-stocks-amd-esperion-therapeutics-nokia-and-more.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Here's how to trade six of the most active names on the market this afternoon.
ARRY,ARRY:US,BBG000C52TW3,"How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More",2017-03-20 18:03:00 +0000,https://www.thestreet.com/story/14051858/1/how-to-trade-monday-s-most-active-stocks-amd-esperion-therapeutics-nokia-and-more.html?puc=yahoo&cm_ven=YAHOO,"How to Trade Monday's Most Active Stocks - AMD, Esperion Therapeutics, Nokia and More"
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Withdraws Cancer Drug Application,2017-03-20 16:38:00 +0000,http://finance.yahoo.com/r/2ce7478a-f9e1-3cca-b2e4-ed87fb8450f3/array-biopharma-withdraws-binimetinib-nda-arry?partner=YahooSA&yptr=yahoo&.tsrc=rss,Array withdrew the FDA application for its skin cancer drug binimetinib after poor Phase 3 results.
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Withdraws Cancer Drug Application,2017-03-20 16:38:00 +0000,http://www.investopedia.com/news/array-biopharma-withdraws-binimetinib-nda-arry/?partner=YahooSA,Array Biopharma Withdraws Cancer Drug Application
ARRY,ARRY:US,BBG000C52TW3,"Apple, Array Biopharma, Alaska Air, and More: Here’s Why These Five Stocks Are in the Spotlight",2017-03-20 13:42:03 +0000,http://www.insidermonkey.com/blog/apple-array-biopharma-alaska-air-and-more-heres-why-these-five-stocks-are-in-the-spotlight-567549/,"Apple, Array Biopharma, Alaska Air, and More: Here’s Why These Five Stocks Are in the Spotlight"
ARRY,ARRY:US,BBG000C52TW3,"Apple, Array Biopharma, Alaska Air, and More: Here’s Why These Five Stocks Are in the Spotlight",2017-03-20 13:42:03 +0000,http://finance.yahoo.com/r/41274dba-a145-3873-b524-7684a88c60e8/apple-array-biopharma-alaska-air-and-more-heres-why-these-five-stocks-are-in-the-spotlight-567549?yptr=yahoo&.tsrc=rss,"It’s the beginning of a new week and the three major indexes look once again to open relatively flat. Although the U.K. plans to start the Brexit next week, investors are complacent as the overall U.S,. economy remains robust. In this article, let’s analyze why Apple Inc. (NASDAQ:AAPL), Tableau Software Inc (NYSE:DATA), Microsoft Corporation (NASDAQ:MSFT), Array Biopharma […]"
ARRY,ARRY:US,BBG000C52TW3,"Biotech Premarket Movers: CytomX, Aevi, Esperion",2017-03-20 13:35:00 +0000,https://www.thestreet.com/story/14051101/1/biotech-premarket-movers.html?puc=yahoo&cm_ven=YAHOO,"Biotech Premarket Movers: CytomX, Aevi, Esperion"
ARRY,ARRY:US,BBG000C52TW3,"Biotech Premarket Movers: CytomX, Aevi, Esperion",2017-03-20 13:35:00 +0000,http://finance.yahoo.com/r/d957a75f-2e6c-359f-bc07-1e3a49d0dab9/biotech-premarket-movers.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Climbs Off Worst Levels But Continues To Post Notable Loss,2017-03-20 13:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/O2p3Dt3rsl4/array-biopharma-climbs-off-worst-levels-but-continues-to-post-notable-loss-20170320-00874,Array BioPharma Climbs Off Worst Levels But Continues To Post Notable Loss
ARRY,ARRY:US,BBG000C52TW3,"Pre-Market Most Active for Mar 20, 2017 :  LYG, ARRY, ESPR, GNMX, HMC, NKTR, DB, SNY, SYT, BAC, ARLZ, ASML",2017-03-20 12:56:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1oVAyHtq-SU/pre-market-most-active-for-mar-20-2017-lyg-arry-espr-gnmx-hmc-nktr-db-sny-syt-bac-arlz-asml-cm762731,The NASDAQ 100 Pre Market Indicator is up 3 9 to 5 412 66 The total Pre Market volume is currently 9 534 783 shares traded The following are the most active stocks for the pre market session Lloyds Banking Group Plc LYG is 0 01 at 3 48 with 2 017 450 shares
ARRY,ARRY:US,BBG000C52TW3,4:16 am Array Biopharma provides update on NEMO; NRAS-mutant melanoma NDA withdrawn based on thorough discussions with FDA,2017-03-20 08:16:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#arry,4:16 am Array Biopharma provides update on NEMO; NRAS-mutant melanoma NDA withdrawn based on thorough discussions with FDA
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Withdraws NDA For Binimetinib Monotherapy,2017-03-19 22:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E2H0hyRRubk/array-biopharma-withdraws-nda-for-binimetinib-monotherapy-20170319-00075,Array BioPharma Withdraws NDA For Binimetinib Monotherapy
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Provides NEMO Update,2017-03-19 21:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-provides-nemo-210000439.html,"[PR Newswire] - BOULDER, Colo., March 19, 2017 /PRNewswire/ -- Array BioPharma Inc. (ARRY) today announced that it has withdrawn from the U.S. Food and Drug Administration's (FDA) Division of Oncology Products 2 its new drug application (NDA) for binimetinib monotherapy for the treatment of NRAS-mutant melanoma, a rare, mutationally-driven subset of skin cancer. Ongoing clinical trials for binimetinib will continue."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Provides NEMO Update,2017-03-19 21:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-provides-nemo-210000439.html?.tsrc=rss,"BOULDER, Colo., March 19, 2017 /PRNewswire/ -- Array BioPharma Inc. (ARRY) today announced that it has withdrawn from the U.S. Food and Drug Administration's (FDA) Division of Oncology Products 2 its new drug application (NDA) for binimetinib monotherapy for the treatment of NRAS-mutant melanoma, a rare, mutationally-driven subset of skin cancer.  Ongoing clinical trials for binimetinib will continue."
ARRY,ARRY:US,BBG000C52TW3,Today's Research Reports on Stocks to Watch: Array Biopharma and Corcept Therapeutics,2017-03-17 13:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-133000015.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 17, 2017 / Array Biopharma and Corcept Therapeutics are two companies whose stock prices both fell on Thursday, following the trend of the general market. Both stocks ..."
ARRY,ARRY:US,BBG000C52TW3,Today's Research Reports on Stocks to Watch: Array Biopharma and Corcept Therapeutics,2017-03-17 13:30:00 +0000,http://finance.yahoo.com/news/todays-research-reports-stocks-watch-133000015.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / March 17, 2017 / Array Biopharma and Corcept Therapeutics are two companies whose stock prices both fell on Thursday, following the trend of the general market. Both stocks ..."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : March 16, 2017",2017-03-16 12:06:17 +0000,http://www.capitalcube.com/blog/index.php/array-biopharma-inc-breached-its-50-day-moving-average-in-a-bearish-manner-arry-us-march-16-2017/,"Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : March 16, 2017"
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : March 16, 2017",2017-03-16 12:06:17 +0000,http://finance.yahoo.com/r/13a21a5d-0e3a-37de-9c6d-edd834ba8b21/array-biopharma-inc-breached-its-50-day-moving-average-in-a-bearish-manner-arry-us-march-16-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Array BioPharma, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more    
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,3 Biotech Stock Rockets With More Fuel in the Tank,2017-03-14 14:07:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/kHBM8RsMr_k/3-biotech-stock-rockets-with-more-fuel-in-the-tank-cm760372,If you bought Cara Therapeutics Inc NASDAQ CARA Array Biopharma Inc NASDAQ ARRY or Corbus Pharmaceuticals Holdings Inc NASDAQ CRBP shares last year then you have a problem the rest of us wish we had These biotech stocks reached stratospheric highs recently
ARRY,ARRY:US,BBG000C52TW3,3 Biotech Stock Rockets With More Fuel in the Tank,2017-03-14 12:02:00 +0000,http://www.fool.com/investing/2017/03/14/3-biotech-stock-rockets-with-more-fuel-in-the-tank.aspx,3 Biotech Stock Rockets With More Fuel in the Tank
ARRY,ARRY:US,BBG000C52TW3,3 Biotech Stock Rockets With More Fuel in the Tank,2017-03-14 12:02:00 +0000,http://finance.yahoo.com/r/541c3362-1663-39d3-806d-82fd7be68f1c/3-biotech-stock-rockets-with-more-fuel-in-the-tank.aspx?yptr=yahoo&.tsrc=rss,"These biotech stocks hit 52-week highs recently, and it looks like there could be more gains ahead."
ARRY,ARRY:US,BBG000C52TW3,Biotech and Pharmaceutical Stocks Fall on Pricing Concerns: Today's Research Reports on Ocera Therapeutics and Array Biopharma,2017-03-09 14:30:00 +0000,http://finance.yahoo.com/news/biotech-pharmaceutical-stocks-fall-pricing-143000130.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / March 9, 2017 / Biotech and Pharmaceutical companies were under attack Tuesday after President Trump tweeted, ""I am working on a new system where there will be competition ..."
ARRY,ARRY:US,BBG000C52TW3,Biotech and Pharmaceutical Stocks Fall on Pricing Concerns: Today's Research Reports on Ocera Therapeutics and Array Biopharma,2017-03-09 14:30:00 +0000,http://finance.yahoo.com/news/biotech-pharmaceutical-stocks-fall-pricing-143000130.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / March 9, 2017 / Biotech and Pharmaceutical companies were under attack Tuesday after President Trump tweeted, ""I am working on a new system where there will be competition ..."
ARRY,ARRY:US,BBG000C52TW3,5 Stock Picks Under $15 to Buy in March,2017-03-05 20:12:42 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V7lffqj_DyA/5-stock-picks-under-15-to-buy-in-march-cm756387,Transocean Offshore NYSE RIG Cliffs Natural Resources NYSE CLF Freeport McMoRan NYSE FCX KBR Inc NYSE KBR and Array BioPharma NASDAQ ARRY are low price stocks with intriguing catalysts that could spark a rally in their share prices Here s why it
ARRY,ARRY:US,BBG000C52TW3,5 Stock Picks Under $15 to Buy in March,2017-03-05 17:41:00 +0000,http://www.fool.com/investing/2017/03/05/5-stock-picks-under-15-to-buy-in-march.aspx,5 Stock Picks Under $15 to Buy in March
ARRY,ARRY:US,BBG000C52TW3,5 Stock Picks Under $15 to Buy in March,2017-03-05 17:41:00 +0000,http://finance.yahoo.com/r/b4a8433f-1f94-3a8f-a447-d57ece0e8457/5-stock-picks-under-15-to-buy-in-march.aspx?yptr=yahoo&.tsrc=rss,"Transocean Offshore, Cliffs Natural Resources, Freeport McMoRan, KBR Inc, and Array BioPharma, may be top low-price stocks worth buying in portfolios now."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference,2017-03-01 14:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-present-cowen-company-140000629.html?.tsrc=rss,"BOULDER, Colo., March 1, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen and Company Annual Healthcare ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Cowen And Company Annual Healthcare Conference,2017-03-01 14:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-present-cowen-company-140000629.html,"[PR Newswire] - BOULDER, Colo., March 1, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cowen and Company Annual Healthcare ..."
ARRY,ARRY:US,BBG000C52TW3,Cramer's lightning round: The only Chinese stock I will recommend,2017-02-28 00:39:29 +0000,http://www.cnbc.com/id/104307657?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104307657,Cramer's lightning round: The only Chinese stock I will recommend
ARRY,ARRY:US,BBG000C52TW3,Cramer's lightning round: The only Chinese stock I will recommend,2017-02-28 00:39:29 +0000,http://finance.yahoo.com/news/cramers-lightning-round-only-chinese-003929830.html?.tsrc=rss,Jim Cramer goes through his lightning round of caller stocks and reveals the only Chinese stock he's willing to warm up to.
ARRY,ARRY:US,BBG000C52TW3,How High Can Array BioPharma Inc. Stock Go?,2017-02-22 19:09:19 +0000,http://www.fool.com/investing/2017/02/21/how-high-can-array-biopharma-stock-go.aspx,How High Can Array BioPharma Inc. Stock Go?
ARRY,ARRY:US,BBG000C52TW3,How High Can Array BioPharma Inc. Stock Go?,2017-02-22 19:09:19 +0000,http://finance.yahoo.com/r/be3c84b7-33e7-3f66-aa74-450cfbd6a1ca/how-high-can-array-biopharma-stock-go.aspx?yptr=yahoo&.tsrc=rss,Array BioPharma has been a huge winner in recent months. Can this biotech stock go much higher?
ARRY,ARRY:US,BBG000C52TW3,How High Can Array BioPharma Inc. Stock Go?,2017-02-21 22:07:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aQNozLT8Jpw/how-high-can-array-biopharma-inc-stock-go-cm750907,A stock that quadruples in 12 months makes investors happy campers That s exactly what Array BioPharma NASDAQ ARRY has done And most of those impressive gains came over the last six months Some stocks experience a letdown after a huge run up like Array has enjoyed So
ARRY,ARRY:US,BBG000C52TW3,Biotech Industry Positioned for a Potential Breakout in 2017: Today's Reports on Array Biopharma and Opko Health,2017-02-17 14:30:00 +0000,http://finance.yahoo.com/news/biotech-industry-positioned-potential-breakout-143000493.html,"[Accesswire] - NEW YORK, NY / ACCESSWIRE / February 17, 2017 / Biotech stocks have continued to outperform the broader markets in 2017 as an expectation of an easier regulatory environment and growing speculation of ..."
ARRY,ARRY:US,BBG000C52TW3,Want to Get In on Biotech? Check Out These 3 Stocks,2017-02-15 16:57:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mIxlOnhZiXA/want-to-get-in-on-biotech-check-out-these-3-stocks-cm748353,For beginning investors the biotech industry can appear somewhat scary Most biotech stocks aren t profitable meaning they re arguably influenced by emotions and clinical trial data more so than any other industry However biotech stocks can also offer significant
ARRY,ARRY:US,BBG000C52TW3,Want to Get In on Biotech? Check Out These 3 Stocks,2017-02-15 14:48:10 +0000,http://finance.yahoo.com/r/bbaf0f5e-6efc-31fa-979a-4c7295d800b8/want-to-get-in-on-biotech-check-out-these-3-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss,"If you're new to biotech investing, these are three companies you need to know."
ARRY,ARRY:US,BBG000C52TW3,Want to Get In on Biotech? Check Out These 3 Stocks,2017-02-15 14:48:10 +0000,http://www.fool.com/investing/2017/02/15/want-to-get-in-on-biotech-check-out-these-3-stocks.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Want to Get In on Biotech? Check Out These 3 Stocks
ARRY,ARRY:US,BBG000C52TW3,"ETFs with exposure to Array BioPharma, Inc. : February 14, 2017",2017-02-14 19:27:59 +0000,http://finance.yahoo.com/r/986b6766-9ff8-3a7e-a8bb-fad3591f6ace/etfs-with-exposure-to-array-biopharma-inc-february-14-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Array BioPharma, Inc. Here are 5 ETFs with the largest exposure to ARRY-US. Comparing the performance and risk of Array BioPharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more    
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,"ETFs with exposure to Array BioPharma, Inc. : February 14, 2017",2017-02-14 19:27:59 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-array-biopharma-inc-february-14-2017/,"ETFs with exposure to Array BioPharma, Inc. : February 14, 2017"
ARRY,ARRY:US,BBG000C52TW3,ARRAY BIOPHARMA INC Financials,2017-02-14 18:04:09 +0000,http://finance.yahoo.com/q/is?s=arry,ARRAY BIOPHARMA INC Financials
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q2, 2017 By the Numbers : February 13, 2017",2017-02-13 15:20:25 +0000,http://www.capitalcube.com/blog/index.php/array-biopharma-inc-arry-us-earnings-analysis-q2-2017-by-the-numbers-february-13-2017/,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q2, 2017 By the Numbers : February 13, 2017"
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q2, 2017 By the Numbers : February 13, 2017",2017-02-13 15:20:25 +0000,http://finance.yahoo.com/r/7a01a058-46e8-3b00-bf41-7f563fb01d78/array-biopharma-inc-arry-us-earnings-analysis-q2-2017-by-the-numbers-february-13-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Array BioPharma, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Array BioPharma, Inc. – Amgen Inc., Celgene Corporation, Astrazeneca PLC Sponsored ADR, Eli Lilly and Company and Novartis AG Sponsored ADR (AMGN-US, CELG-US, AZN-US, LLY-US and NVS-US) that ... Read more    
<b>(Read more...)</b>"
ARRY,ARRY:US,BBG000C52TW3,"After Hours Most Active for Feb 10, 2017 :  KMI, BAC, CTB, KO, WFT, KKR, FB, MENT, ARRY, MSFT, SGYP, MU",2017-02-10 21:57:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/58Jr5jKs7zI/after-hours-most-active-for-feb-10-2017-kmi-bac-ctb-ko-wft-kkr-fb-ment-arry-msft-sgyp-mu-cm746577,The NASDAQ 100 After Hours Indicator is down 1 62 to 5 225 07 The total After hours volume is currently 30 103 756 shares traded The following are the most active stocks for the after hours session Kinder Morgan Inc KMI is 0 0317 at 22 45 with 8 050 347
ARRY,ARRY:US,BBG000C52TW3,Is Array BioPharma the Best Clinical-Stage Biotech Stock to Buy in 2017?,2017-02-10 15:20:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sJkRsM0MgXU/is-array-biopharma-the-best-clinical-stage-biotech-stock-to-buy-in-2017-cm746205,Increasingly complex cancer medicines are launching with six figure price tags and a larger longer living population means that global cancer drug spending is soaring Many clinical stage biotech stocks are working on new drugs that could capitalize on this growth but Array
ARRY,ARRY:US,BBG000C52TW3,Is Array BioPharma the Best Clinical-Stage Biotech Stock to Buy in 2017?,2017-02-10 13:22:27 +0000,http://www.fool.com/investing/2017/02/10/is-array-biopharma-the-best-clinical-stage-biotech.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Is Array BioPharma the Best Clinical-Stage Biotech Stock to Buy in 2017?
ARRY,ARRY:US,BBG000C52TW3,Here's Why Array Biopharma Inc Stock Is Climbing Again Today,2017-02-09 23:19:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bIcWGCGYvo0/heres-why-array-biopharma-inc-stock-is-climbing-again-today-cm745895,What happened Shares of Array Biopharma Inc NASDAQ ARRY 160 a clinical stage biotech with a focus on cancer gained 17 38 as of 4 p m EST on Thursday Included in its fiscal second quarter 2017 earnings report this morning was some good news involving a combination
ARRY,ARRY:US,BBG000C52TW3,Here's Why Array Biopharma Inc Stock Is Climbing Again Today,2017-02-09 21:33:29 +0000,http://www.fool.com/investing/2017/02/09/heres-why-array-biopharma-inc-stock-is-climbing-ag.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Array Biopharma Inc Stock Is Climbing Again Today
ARRY,ARRY:US,BBG000C52TW3,Edited Transcript of ARRY earnings conference call or presentation 9-Feb-17 2:00pm GMT,2017-02-09 20:28:58 +0000,http://finance.yahoo.com/news/edited-transcript-arry-earnings-conference-202858103.html,Edited Transcript of ARRY earnings conference call or presentation 9-Feb-17 2:00pm GMT
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma 4Q Loss 14c/Share Beats Street,2017-02-09 17:22:00 +0000,http://www.investopedia.com/news/array-biopharma-2q-loss-beats-street-arry/?partner=YahooSA,Array BioPharma 4Q Loss 14c/Share Beats Street
ARRY,ARRY:US,BBG000C52TW3,Health Care Sector Update for 02/09/2017: ARRY,2017-02-09 14:57:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5yjkNncEOJc/health-care-sector-update-for-02092017-arry-cm745433,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 5 PFE 0 5 ABT 0 2 ABT 0 2 MRK flatMRK flat AMGN 1 5 AMGN 1 5 Health care shares were mixed in pre market trade on Thursday Health care shares were mixed in pre market trade on Thursday In health care
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today,2017-02-09 14:00:00 +0000,http://biz.yahoo.com/cc/3/155463.html,Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma reports 2Q loss,2017-02-09 13:47:35 +0000,http://sg.finance.yahoo.com/news/array-biopharma-reports-2q-loss-134735022.html,Array BioPharma reports 2Q loss
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib",2017-02-09 13:33:48 +0000,http://biz.yahoo.com/e/170209/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Reports Financial Results For The Second Quarter Of Fiscal 2017,2017-02-09 13:30:00 +0000,http://finance.yahoo.com/news/array-biopharma-reports-financial-results-133000957.html,"[PR Newswire] - BOULDER, Colo., Feb. 9, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule cancer ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report",2017-02-09 13:14:04 +0000,http://biz.yahoo.com/e/170209/arry10-q.html,"ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report"
ARRY,ARRY:US,BBG000C52TW3,Q2 2017 Array Biopharma Inc Earnings Release - Before Market Open,2017-02-09 12:07:05 +0000,http://biz.yahoo.com/research/earncal/20170209.html?t=arry,Q2 2017 Array Biopharma Inc Earnings Release - Before Market Open
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Q2 17 Earnings Conference Call At 9:00 AM ET,2017-02-09 08:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/iVM6Yp040t8/array-biopharma-q2-17-earnings-conference-call-at-900-am-et-20170209-00662,Array BioPharma Q2 17 Earnings Conference Call At 9:00 AM ET
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Leerink Partners Annual Global Healthcare Conference,2017-02-08 14:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-present-leerink-partners-140000458.html,"[PR Newswire] - BOULDER, Colo., Feb. 8, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Leerink Partners Annual Global Healthcare ..."
ARRY,ARRY:US,BBG000C52TW3,"Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More",2017-02-03 13:19:00 +0000,http://finance.yahoo.com/news/analysts-actions-eaton-ford-altria-131900212.html,"Analysts' Actions -- Eaton, Ford, Altria, Ralph Lauren and More"
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma downgraded by JP Morgan,2017-02-03 12:10:26 +0000,http://finance.yahoo.com/q/ud?s=ARRY,Array Biopharma downgraded by JP Morgan
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Soared 23.7% in January,2017-02-02 22:33:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8auimnFw4GA/why-array-biopharma-soared-237-in-january-cm742511,IMAGE SOURCE GETTY IMAGES What happened After Array BioPharma NASDAQ ARRY 160 updated 160 investors on its progress toward its first commercial stage medicine at the JP Morgan Healthcare Conference in early January its stock rose 23 7 higher
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Soared 23.7% in January,2017-02-02 21:22:06 +0000,http://www.fool.com/investing/2017/02/02/why-array-biopharma-soared-237-in-january.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Array BioPharma Soared 23.7% in January
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma to Report Financial Results for the Second Quarter of Fiscal 2017 on February 9, 2017",2017-02-02 19:55:00 +0000,http://finance.yahoo.com/news/array-biopharma-report-financial-results-195500800.html,"[PR Newswire] - BOULDER, Colo., Feb. 2, 2017 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) will report financial results for the second quarter of fiscal 2017 and hold a conference call to discuss those results ..."
ARRY,ARRY:US,BBG000C52TW3,"I-O Players Incyte, Roche Squeeze Array's Melanoma Market: Leerink",2017-01-30 21:32:30 +0000,http://www.investors.com/news/technology/i-o-players-incyte-roche-squeeze-arrays-melanoma-market-leerink/,"I-O Players Incyte, Roche Squeeze Array's Melanoma Market: Leerink"
ARRY,ARRY:US,BBG000C52TW3,"Analysts' Actions -- Air Products, Disney, Colgate-Palmolive, Noble and More",2017-01-30 13:17:00 +0000,http://finance.yahoo.com/news/analysts-actions-air-products-disney-131700390.html,"Analysts' Actions -- Air Products, Disney, Colgate-Palmolive, Noble and More"
ARRY,ARRY:US,BBG000C52TW3,"Sanctuary Wealth Advisors, LLC Buys US Silica Holdings Inc, Oasis Petroleum Inc, Array ...",2017-01-24 12:30:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/54afgtv_gt4/sanctuary-wealth-advisors-llc-buys-us-silica-holdings-inc-oasis-petroleum-inc-array-cm737120,Sanctuary Wealth Advisors LLC New Purchases SLCA OAS ARRY S ZION NAV CLVS UBNT TSRO ECA Added Positions OCLR WIX DMLP SU DISH AESPRC HGT SATS EDE Reduced Positions NVDA AMD PNC INCY SJT QQQ JBT MCD DIA IWM Sold Out YELP
ARRY,ARRY:US,BBG000C52TW3,3 Stocks That Tripled,2017-01-21 14:37:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/einBp0dlVw8/3-stocks-that-tripled-cm736332,Image source Getty Images The stock market had a good year in 2016 with double digit percentage returns rewarding investors who stayed invested despite the aging bull market Yet even though those gains are solid they pale in comparison to the much larger increases in share
ARRY,ARRY:US,BBG000C52TW3,3 Stocks That Tripled,2017-01-21 13:24:07 +0000,http://www.fool.com/investing/2017/01/21/3-stocks-that-tripled.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Stocks That Tripled
ARRY,ARRY:US,BBG000C52TW3,Cramer says take off half and play with the house's money on this stock,2017-01-21 00:22:46 +0000,http://www.cnbc.com/id/104231842?__source=yahoo%7cfinance%7cheadline%7cheadline%7cstory&par=yahoo&doc=104231842,[at CNBC] - Jim Cramer rattles off his take on various caller stocks in the lightning round.
ARRY,ARRY:US,BBG000C52TW3,Will Array BioPharma (ARRY) Continue to Surge Higher?,2017-01-20 11:38:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/4sAsTudmD4o/will-array-biopharma-arry-continue-to-surge-higher-cm735790,As of late it has definitely been a great time to be an investor in Array BioPharma Inc ARRY The stock has moved higher by 31 1 in the past month while it is also above its 20 Day SMA too This combination of strong price performance and favorable technical could suggest that the stock
ARRY,ARRY:US,BBG000C52TW3,Will Array BioPharma (ARRY) Continue to Surge Higher?,2017-01-20 09:38:09 +0000,http://finance.yahoo.com/news/array-biopharma-arry-continue-surge-093809687.html,Will Array BioPharma (ARRY) Continue to Surge Higher?
ARRY,ARRY:US,BBG000C52TW3,Energy And Biotech Momentum Stocks To Watch,2017-01-19 00:41:00 +0000,http://www.forbes.com/sites/greatspeculations/2017/01/18/energy-and-biotech-momentum-stocks-to-watch/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Energy And Biotech Momentum Stocks To Watch
ARRY,ARRY:US,BBG000C52TW3,4 Momentum Charts to Watch,2017-01-18 18:12:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5yTyyKMRKos/4-momentum-charts-to-watch-cm734954,"By Harry Boxer,  TheTechTrader.com    Here are four stocks to watch with strong technical patterns.   Array BioPharma Inc. ( ARRY ) , which rallied over 7% on Friday on no news, followed through for another 3.4%, or 37 cents, to 11.24 on Tuesday on a market down-day.  Volume was a strong 8.5 million shares, and the"
ARRY,ARRY:US,BBG000C52TW3,"Zacks Investment Ideas feature highlights: Array BioPharma, BHP Billition, MSC Industrial Direct, Rio Tinto and Vantiv",2017-01-16 16:37:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/r9IW7G3WsD0/zacks-investment-ideas-feature-highlights-array-biopharma-bhp-billition-msc-industrial-direct-rio-tinto-and-vantiv-cm733903,For Immediate Release Chicago IL January 16 2017 Today Zacks Investment Ideas feature highlights Features Array BioPharma NASDAQ ARRY Free Report BHP Billition NYSE BHP Free Report MSC Industrial Direct NYSE MSM Free Report Rio Tinto NYSE
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) Jumps: Stock Adds 7.5% in Session,2017-01-16 15:39:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Q9-NwV45G4/array-biopharma-arry-jumps-stock-adds-75-in-session-cm733876,Array BioPharma Inc ARRY was a big mover last session as the company saw its shares rise over 7 on the day The move came on solid volume with far more shares changing hands than in a normal session This continues the recent uptrend of the company as the stock is now up 24 in the
ARRY,ARRY:US,BBG000C52TW3,"Zacks Investment Ideas feature highlights: Array BioPharma, BHP Billition, MSC Industrial Direct, Rio Tinto and Vantiv",2017-01-16 14:30:02 +0000,http://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-143002661.html,"Zacks Investment Ideas feature highlights: Array BioPharma, BHP Billition, MSC Industrial Direct, Rio Tinto and Vantiv"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) Jumps: Stock Adds 7.5% in Session,2017-01-16 13:30:01 +0000,http://finance.yahoo.com/news/array-biopharma-arry-jumps-stock-133001445.html,Array BioPharma (ARRY) Jumps: Stock Adds 7.5% in Session
ARRY,ARRY:US,BBG000C52TW3,Nasdaq Hits New High as Dow Jones Industrial Average Lags,2017-01-13 22:37:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/W1bOhTje7M0/nasdaq-hits-new-high-as-dow-jones-industrial-average-lags-cm733522,Bank stocks boosted the broader stock market following well received earnings reports but it wasn t enough to keep the 160 Dow Jones Industrial Average DJIA afloat In fact the Dow erased its midday gains putting the 20 000 mark further in the rearview mirror ahead of the long
ARRY,ARRY:US,BBG000C52TW3,Mid-Afternoon Market Update: Dow Turns Negative; Sanchez Energy Shares Spike Higher,2017-01-13 20:56:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-GwORAWhxyY/mid-afternoon-market-update-dow-turns-negative-sanchez-energy-shares-spike-higher-cm733497,Toward the end of trading Friday the Dow traded down 0 13 percent to 19 864 29 while the NASDAQ climbed 0 48 percent to 5 573 96 The S amp P also rose gaining 0 13 percent to 2 273 27 Leading and Lagging Sectors Healthcare shares gained around 0 43 percent in trading on
ARRY,ARRY:US,BBG000C52TW3,"Friday's ETF Movers: XBI, GDXJ",2017-01-13 19:37:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GMOI-mdCAYA/fridays-etf-movers-xbi-gdxj-cm733435,In trading on Friday the SPDR S amp P Biotech ETF XBI is outperforming other ETFs up about 1 9 on the day Components of that ETF showing particular strength include shares of Amicus Therapeutics FOLD up about 9 8 and shares of Array Biopharma ARRY up about 8 8 on the
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At J.P. Morgan Conference ; Webcast At 11:30 AM ET,2017-01-11 10:31:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ixp1BXc86wk/array-biopharma-to-present-at-jp-morgan-conference--webcast-at-1130-am-et-20170111-00527,Array BioPharma To Present At J.P. Morgan Conference ; Webcast At 11:30 AM ET
ARRY,ARRY:US,BBG000C52TW3,"After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next",2017-01-10 18:52:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E305Mk4Dbx0/after-ariads-acquisition-these-3-cancer-drug-stocks-could-be-next-cm731788,Japanese drugmaker Takeda Pharmaceutical Company NASDAQOTH TKPYY 160 announced yesterday that it s acquiring ARIAD Pharmaceuticals NASDAQ ARIA 160 for 24 per share or 5 2 billion The deal removes yet another commercial stage cancer drugmaker from the market and
ARRY,ARRY:US,BBG000C52TW3,"After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next",2017-01-10 17:21:07 +0000,http://www.fool.com/investing/2017/01/10/3-cancer-stocks-that-could-be-next-to-get-acquired.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"After ARIAD's Acquisition, These 3 Cancer Drug Stocks Could Be Next"
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Inc Stock Surged 108.3% in 2016,2017-01-09 16:52:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DBxrRSFI7Nc/why-array-biopharma-inc-stock-surged-1083-in-2016-cm731078,Image source Getty Images What happened Cancer focused Array Biopharma Inc NASDAQ ARRY delighted investors with a stellar 108 3 gain last year according to data from S amp P Global Market Intelligence Positive developments for its late stage drug development
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Inc Stock Surged 108.3% in 2016,2017-01-09 15:26:24 +0000,http://www.fool.com/investing/2017/01/09/why-array-biopharma-inc-stock-surged-1083-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Array BioPharma Inc Stock Surged 108.3% in 2016
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference,2017-01-03 14:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-present-annual-j-140000544.html,"[PR Newswire] - BOULDER, Colo., Jan. 3, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit",2016-12-23 21:04:22 +0000,http://biz.yahoo.com/e/161223/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material Definit"
ARRY,ARRY:US,BBG000C52TW3,"Commit To Purchase Array BioPharma At $4, Earn 13.8% Using Options",2016-12-22 17:58:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uZeKd4krc4Q/commit-to-purchase-array-biopharma-at-4-earn-138-using-options-cm725221,Investors considering a purchase of Array BioPharma Inc Symbol ARRY shares but tentative about paying the going market price of 8 60 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
ARRY,ARRY:US,BBG000C52TW3,Is Array Biopharma Inc (ARRY) A Good Stock To Buy?,2016-12-11 14:39:34 +0000,http://www.insidermonkey.com/blog/is-array-biopharma-inc-arry-a-good-stock-to-buy-2-500391/,Is Array Biopharma Inc (ARRY) A Good Stock To Buy?
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Rose 32.5% in November,2016-12-03 20:33:56 +0000,http://www.fool.com/investing/2016/12/03/why-array-biopharma-rose-32-in-november.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Array BioPharma Rose 32.5% in November
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference,2016-11-22 15:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-present-piper-jaffray-150000212.html,"[PR Newswire] - BOULDER, Colo., Nov. 22, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare conference. The ..."
ARRY,ARRY:US,BBG000C52TW3,Trade of the Day: Array BioPharma (NASDAQ:ARRY),2016-11-17 16:53:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/R0OmZOxxvFY/trade-of-the-day-array-biopharma-nasdaqarry-cm710648,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Shares of Array BioPharma 160 NASDAQ ARRY could be on the move today as CEO Ron Squarer is speaking at the Jefferies 2016 Global Healthcare Conference with talking
ARRY,ARRY:US,BBG000C52TW3,"Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks?",2016-11-15 17:27:29 +0000,http://www.insidermonkey.com/blog/is-redmile-group-right-to-bet-on-array-biopharma-inc-arry-amicus-therapeutics-inc-fold-two-other-stocks-487363/,"Is Redmile Group Right to Bet on Array Biopharma Inc (ARRY), Amicus Therapeutics, Inc. (FOLD) & Two Other Stocks?"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At Stifel Healthcare Conferences; Webcast At 10:15 AM,2016-11-15 09:15:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MXUofsWGwag/array-biopharma-to-present-at-stifel-healthcare-conferences-webcast-at-1015-am-20161115-00726,Array BioPharma To Present At Stifel Healthcare Conferences; Webcast At 10:15 AM
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Inc (ARRY) Updates On COLUMBUS Phase 3 And It’s Impressive,2016-11-10 16:07:49 +0000,http://www.insidermonkey.com/blog/array-biopharma-inc-arry-updates-on-columbus-phase-3-and-its-impressive-486778/,Array Biopharma Inc (ARRY) Updates On COLUMBUS Phase 3 And It’s Impressive
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Inc (ARRY) Stock: Gaining Big On Clinical Data,2016-11-10 08:06:24 +0000,http://www.insidermonkey.com/blog/array-biopharma-inc-arry-stock-gaining-big-on-clinical-data-486368/,Array Biopharma Inc (ARRY) Stock: Gaining Big On Clinical Data
ARRY,ARRY:US,BBG000C52TW3,The Market Offers Some Opportunities but They're Disappearing Fast,2016-11-09 15:19:00 +0000,http://realmoney.thestreet.com/articles/11/09/2016/market-offers-some-opportunities-theyre-disappearing-fast?puc=yahoo&cm_ven=YAHOO,The Market Offers Some Opportunities but They're Disappearing Fast
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-11-09 15:17:46 +0000,http://biz.yahoo.com/e/161109/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
ARRY,ARRY:US,BBG000C52TW3,COLUMBUS Phase 3 Study Results in BRAF-Mutant Melanoma Presented at Society for Melanoma Research Annual Congress,2016-11-09 15:00:00 +0000,http://finance.yahoo.com/news/columbus-phase-3-study-results-150000489.html,"[PR Newswire] - BOULDER, Colo., and CASTRES, France, Nov. 9, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today jointly announced new results from the pivotal Phase 3 COLUMBUS trial of binimetinib ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Stifel 2016 Healthcare And Jefferies 2016 Global Healthcare Conferences,2016-11-08 19:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-present-stifel-2016-190000266.html,"[PR Newswire] - BOULDER, Colo., Nov. 8, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences. The public ..."
ARRY,ARRY:US,BBG000C52TW3,7 Analyst Stocks Under $10 for Massive Upside Projections,2016-11-06 15:15:56 +0000,http://247wallst.com/investing/2016/11/06/7-analyst-stocks-under-10-for-massive-upside-projections/,7 Analyst Stocks Under $10 for Massive Upside Projections
ARRY,ARRY:US,BBG000C52TW3,"Top Analyst Upgrades and Downgrades: Agrium, Array BioPharma, Encana, GoPro, 3D Systems and More",2016-11-04 12:50:37 +0000,http://247wallst.com/investing/2016/11/04/top-analyst-upgrades-and-downgrades-agrium-array-biopharma-encana-gopro-3d-systems-and-more/,"Top Analyst Upgrades and Downgrades: Agrium, Array BioPharma, Encana, GoPro, 3D Systems and More"
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report",2016-11-03 12:38:37 +0000,http://biz.yahoo.com/e/161103/arry10-q.html,"ARRAY BIOPHARMA INC Files SEC form 10-Q, Quarterly Report"
ARRY,ARRY:US,BBG000C52TW3,Edited Transcript of ARRY earnings conference call or presentation 1-Nov-16 1:00pm GMT,2016-11-01 20:01:52 +0000,http://finance.yahoo.com/news/edited-transcript-arry-earnings-conference-200152498.html,Edited Transcript of ARRY earnings conference call or presentation 1-Nov-16 1:00pm GMT
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today,2016-11-01 13:00:00 +0000,http://biz.yahoo.com/cc/1/154511.html,Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma reports 1Q loss,2016-11-01 12:30:51 +0000,http://sg.finance.yahoo.com/news/array-biopharma-reports-1q-loss-123051594.html,Array BioPharma reports 1Q loss
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Reports Financial Results For The First Quarter Of Fiscal 2017,2016-11-01 12:14:53 +0000,http://www.publicnow.com/view/0333C90FCEA98D7E118C4E86032B00CD4E4B0D3B,"[at noodls] - BOULDER, Colo., Nov. 1, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule cancer ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib",2016-11-01 12:03:17 +0000,http://biz.yahoo.com/e/161101/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib"
ARRY,ARRY:US,BBG000C52TW3,Q1 2017 Array Biopharma Inc Earnings Release - Before Market Open,2016-11-01 11:07:06 +0000,http://biz.yahoo.com/research/earncal/20161101.html?t=arry,Q1 2017 Array Biopharma Inc Earnings Release - Before Market Open
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Q1 17 Earnings Conference Call At 9:00 AM ET,2016-11-01 08:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/amJx-_ttlG4/array-biopharma-q1-17-earnings-conference-call-at-900-am-et-20161101-01692,Array BioPharma Q1 17 Earnings Conference Call At 9:00 AM ET
ARRY,ARRY:US,BBG000C52TW3,"Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed",2016-10-31 18:09:00 +0000,http://realmoney.thestreet.com/articles/10/31/2016/take-chill-pill-if-clinton-wins-drug-price-controls-arent-guaranteed?puc=yahoo&cm_ven=YAHOO,"Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed"
ARRY,ARRY:US,BBG000C52TW3,"Research Reports on Biotech Equities -- Mast Therapeutics, Array BioPharma, Galena Biopharma, and Clovis Oncology",2016-10-31 15:08:00 +0000,http://finance.yahoo.com/news/research-reports-biotech-equities-mast-150800017.html,"[PR Newswire] - Growing concerns that a victory by Democratic nominee Hillary Clinton in the presidential election will result in tighter regulations on pricing for new drugs, continues to disturb the Biotechnology arena, which has already tanked 15.53% this year, as per Investopedia data. Today, Stock-Callers.com reviews the performances of Mast Therapeutics Inc. (NYSE MKT: MSTX), Array BioPharma Inc. (ARRY), Galena Biopharma Inc. (GALE), and Clovis Oncology Inc. (CLVS) to see how they have fared over the last few trading sessions. Shares in California headquartered Mast Therapeutics Inc. ended Friday's session flat at $0.08 with a total trading volume of 2.78 million shares. Shares of the Company, which develops therapies for serious or life-threatening diseases with significant unmet needs, have a Relative Strength Index (RSI) of 32.10."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma And Pierre Fabre To Present Phase 3 COLUMBUS Trial At Society For Melanoma Research Annual Congress,2016-10-25 20:31:00 +0000,http://finance.yahoo.com/news/array-biopharma-pierre-fabre-present-203100437.html,"[PR Newswire] - BOULDER, Colo., and CASTRES, France, Oct. 25, 2016 /PRNewswire/ -- Array BioPharma (NASDAQ: ARRY) and Pierre Fabre announced today that results from the Phase 3 COLUMBUS trial of binimetinib and encorafenib ..."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma To Report Financial Results For The First Quarter Of Fiscal 2017 On November 1, 2016",2016-10-25 15:25:01 +0000,http://www.publicnow.com/view/0129FFDFD487D0FB1F2F71D97328524356DEBE0F,"[at noodls] - BOULDER, Colo., Oct. 25, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the first quarter of fiscal 2017 and hold a conference call to discuss those results ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) is in Overbought Territory: What's Next?,2016-10-14 16:43:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Y35FzUA1oHE/array-biopharma-arry-is-in-overbought-territory-whats-next-cm693531,Array BioPharma Inc ARRY has moved higher as of late but there could definitely be trouble on the horizon for this company That is because ARRY is now in overbought territory with an RSI value of 72 03 What is RSI 160 160 160 160 160 160 RSI stands for Relative
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) is in Overbought Territory: What's Next?,2016-10-14 14:10:02 +0000,http://finance.yahoo.com/news/array-biopharma-arry-overbought-territory-141002020.html,Array BioPharma (ARRY) is in Overbought Territory: What's Next?
ARRY,ARRY:US,BBG000C52TW3,"ETF’s with exposure to Array BioPharma, Inc. : October 11, 2016",2016-10-11 14:05:20 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-array-biopharma-inc-october-11-2016/,"ETF’s with exposure to Array BioPharma, Inc. : October 11, 2016"
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Skyrocketed 91% in September,2016-10-10 17:19:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HkkL6aAl2ww/why-array-biopharma-skyrocketed-91-in-september-cm691183,Image source Getty Images What happened After reporting that the FDA has accepted its application for approval of binimetinib and delivering positive trial results from a study of binimetinib and encorafenib combination therapy shares in Array BioPharma NASDAQ
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Skyrocketed 91% in September,2016-10-10 15:21:06 +0000,http://www.fool.com/investing/2016/10/10/why-array-biopharma-skyrocketed-91-in-september.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Array BioPharma Skyrocketed 91% in September
ARRY,ARRY:US,BBG000C52TW3,3 Cancer Drugs That Could Get an FDA OK Next Year,2016-10-09 16:20:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PW6HQYKqJMg/3-cancer-drugs-that-could-get-an-fda-ok-next-year-cm690778,Image source Getty Images Significant spending on cancer research and development could be about to pay off for Clovis Oncology NASDAQ CLVS Array BioPharma NASDAQ ARRY and Ariad Pharmaceuticals NASDAQ ARIA All three of these companies are preparing for
ARRY,ARRY:US,BBG000C52TW3,3 Cancer Drugs That Could Get an FDA OK Next Year,2016-10-09 15:13:33 +0000,http://www.fool.com/investing/2016/10/09/3-cancer-drugs-that-could-get-a-fda-ok-next-year.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Cancer Drugs That Could Get an FDA OK Next Year
ARRY,ARRY:US,BBG000C52TW3,6 Best Performing Drug Stocks of September,2016-10-03 14:47:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5jt2X9_U-eY/6-best-performing-drug-stocks-of-september-cm687686,Pharma and biotech stocks have been under a lot of pressure over the last few quarters with the NYSE ARCA Pharmaceutical Index and the NASDAQ Biotechnology index declining 4 1 and 11 7 respectively so far in 2016 Factors like the drug pricing controversy and a changing competitive
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares,2016-10-03 14:36:02 +0000,http://www.publicnow.com/view/62BDC19FCCC55306256AA5A9938DFE21F1729EC5,"[at noodls] - BOULDER, Colo., Oct. 3, 2016 /PRNewswire/ -- Array BioPharma Inc. (NasdaqGM: ARRY) announced today the closing of its underwritten public offering of 21,160,000 shares of its common stock, which includes ..."
ARRY,ARRY:US,BBG000C52TW3,6 Best Performing Drug Stocks of September,2016-10-03 12:39:12 +0000,http://finance.yahoo.com/news/6-best-performing-drug-stocks-123912721.html,6 Best Performing Drug Stocks of September
ARRY,ARRY:US,BBG000C52TW3,Top 6 Biopharma Gainers of the Past Week,2016-10-02 14:05:42 +0000,http://247wallst.com/healthcare-business/2016/10/02/top-6-biopharma-gainers-of-the-past-week/,Top 6 Biopharma Gainers of the Past Week
ARRY,ARRY:US,BBG000C52TW3,5 Top Performing Stocks of the Best ETF of Q3,2016-09-30 15:24:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1i38wrWT5co/5-top-performing-stocks-of-the-best-etf-of-q3-cm687111,After a huge sell off at the start of the year the biotech sector has made a strong comeback with BioShares Biotechnology Clinical Trials Fund BBC topping the list of the best performing ETFs of 3Q16 The fund delivered impressive returns of about 29 6 in the quarter and has a Zacks ETF Rank
ARRY,ARRY:US,BBG000C52TW3,Array Announces $100M Public Offering (ARRY),2016-09-30 03:12:00 +0000,http://www.investopedia.com/news/array-announces-100m-public-offering-arry/?partner=YahooSA,Array Announces $100M Public Offering (ARRY)
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Reports Positive Results (ARRY),2016-09-28 21:55:00 +0000,http://www.investopedia.com/news/array-biopharma-reports-positive-results-arry/?partner=YahooSA,Array BioPharma Reports Positive Results (ARRY)
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement",2016-09-28 20:50:37 +0000,http://biz.yahoo.com/e/160928/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statement"
ARRY,ARRY:US,BBG000C52TW3,"Why Wells Fargo, Select Comfort, Array Biopharma, American Express, and More Are Trending",2016-09-28 13:59:03 +0000,http://www.insidermonkey.com/blog/why-wells-fargo-select-comfort-array-biopharma-american-express-and-more-are-trending-477278/,"Why Wells Fargo, Select Comfort, Array Biopharma, American Express, and More Are Trending"
ARRY,ARRY:US,BBG000C52TW3,"Pre-Market Most Active for Sep 28, 2016 :  GXP, ARRY, SNY, LN, BBRY, DB, SEED, TWTR, COTY, QQQ, AAPL, SRPT",2016-09-28 12:51:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/umHCRPi5m0A/pre-market-most-active-for-sep-28-2016-gxp-arry-sny-ln-bbry-db-seed-twtr-coty-qqq-aapl-srpt-cm685782,The NASDAQ 100 Pre Market Indicator is up 3 14 to 4 869 85 The total Pre Market volume is currently 8 329 979 shares traded The following are the most active stocks for the pre market session Great Plains Energy Inc GXP is 0 35 at 26 81 with 3 177 250 shares
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Pricing of Public Offering of Common Stock,2016-09-28 01:39:07 +0000,http://www.publicnow.com/view/BE401854E6031C76E0372672777F650778B222FB,"[at noodls] - BOULDER, Colo., Sept. 27, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) announced today the pricing of an underwritten public offering of 18,400,000 shares of its common stock at a public offering ..."
ARRY,ARRY:US,BBG000C52TW3,3 Reasons to Buy Array Biopharma,2016-09-28 00:21:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ovgCRTDeCuU/3-reasons-to-buy-array-biopharma-cm685701,Image source Array BioPharma Array BioPharma Inc NASDAQ ARRY shares are soaring recently following a slate of good news Is there more room left to run Read on to find out why I think if management delivers on these three catalysts this stock can trade higher No
ARRY,ARRY:US,BBG000C52TW3,3 Reasons to Buy Array Biopharma,2016-09-27 22:20:00 +0000,http://www.fool.com/investing/2016/09/27/3-reasons-to-buy-array-biopharma.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Reasons to Buy Array Biopharma
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Prices Offering Of 18.40 Mln Shares At $6.25/shr,2016-09-27 21:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jq5e_h_Ug0w/array-biopharma-prices-offering-of-1840-mln-shares-at-625shr-20160927-00758,Array BioPharma Prices Offering Of 18.40 Mln Shares At $6.25/shr
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Proposed Public Offering of Common Stock,2016-09-27 20:39:05 +0000,http://www.publicnow.com/view/4105EDA1E1D46C9C4977887EE8E826AD41CE8D5C,"[at noodls] - BOULDER, Colo., Sept. 27, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) today announced that it has commenced an underwritten public offering of $100 million of shares of its common stock. Array ..."
ARRY,ARRY:US,BBG000C52TW3,"ProNAi Therapeutics Inc. (DNAI), Ballard Power Systems Inc. (USA) (BLDP) & More: Major Hype Surrounding These Stocks Today",2016-09-27 18:01:25 +0000,http://www.insidermonkey.com/blog/pronai-therapeutics-inc-dnai-ballard-power-systems-inc-usa-bldp-more-major-hype-surrounding-these-stocks-today-477197/,"ProNAi Therapeutics Inc. (DNAI), Ballard Power Systems Inc. (USA) (BLDP) & More: Major Hype Surrounding These Stocks Today"
ARRY,ARRY:US,BBG000C52TW3,2 Longs And 2 Shorts to Watch,2016-09-27 17:00:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/oH4cfiLHY6k/2-longs-and-2-shorts-to-watch-cm685486,"Array BioPharma Inc. ( ARRY ) had an explosive move on Monday, up $2.96, or 81%, to $6.61, on 101 million shares.  The company said its melanoma treatment met its primary goal in a late-stage trial.  Afterhours the stock was trading even higher, and looks like it has more room to run.  There's key resistance between"
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma (ARRY) Stock Up, JPMorgan Raises Price Target on Drug Success",2016-09-27 16:50:00 +0000,https://www.thestreet.com/story/13753677/1/array-biopharma-arry-stock-up-jpmorgan-raises-price-target-on-drug-success.html?puc=yahoo&cm_ven=YAHOO,"Array BioPharma (ARRY) Stock Up, JPMorgan Raises Price Target on Drug Success"
ARRY,ARRY:US,BBG000C52TW3,"Momentum Carries Lululemon Lower, Pushes Biotech Names Higher",2016-09-27 15:49:00 +0000,http://www.forbes.com/sites/greatspeculations/2016/09/27/momentum-carries-lululemon-lower-pushes-biotech-names-higher/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,"Momentum Carries Lululemon Lower, Pushes Biotech Names Higher"
ARRY,ARRY:US,BBG000C52TW3,Array (ARRY) Hits 52-Week High on Positive Phase III Data,2016-09-27 15:24:10 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fAmlk8KAmqk/array-arry-hits-52-week-high-on-positive-phase-iii-data-cm685278,Array BioPharma Inc ARRY along with its partner Pierre Fabre announced positive top line data from part 1 of the phase III study COLUMBUS on a combination of encorafenib BRAF inhibitor and binimetinib MEK inhibitor for the treatment of BRAF mutant advanced unresectable or
ARRY,ARRY:US,BBG000C52TW3,"3 Stocks to Watch Tuesday: Kite Pharma Inc (KITE), Array Biopharma Inc (ARRY) and Mylan NV (MYL)",2016-09-27 15:21:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-F4eWgk9_5M/3-stocks-to-watch-tuesday-kite-pharma-inc-kite-array-biopharma-inc-arry-and-mylan-nv-myl-cm685270,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Monday was a straight up lousy day for the major U S stock indices on a day that saw oil slip 4 sending energy stocks broadly down 1 3 The S amp P 500 Index fell 0 86 the Dow
ARRY,ARRY:US,BBG000C52TW3,"ETF’s with exposure to Array BioPharma, Inc. : September 27, 2016",2016-09-27 13:51:38 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-array-biopharma-inc-september-27-2016/,"ETF’s with exposure to Array BioPharma, Inc. : September 27, 2016"
ARRY,ARRY:US,BBG000C52TW3,Array (ARRY) Hits 52-Week High on Positive Phase III Data,2016-09-27 13:42:01 +0000,http://finance.yahoo.com/news/array-arry-hits-52-week-134201633.html,Array (ARRY) Hits 52-Week High on Positive Phase III Data
ARRY,ARRY:US,BBG000C52TW3,"Pre-Market Most Active for Sep 27, 2016 :  RICE, ARRY, TWTR, MPW, DB, LYG, GI, XIV, QQQ, TVIX, AAPL, NVAX",2016-09-27 12:51:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_iKIXzIABXM/pre-market-most-active-for-sep-27-2016-rice-arry-twtr-mpw-db-lyg-gi-xiv-qqq-tvix-aapl-nvax-cm684994,The NASDAQ 100 Pre Market Indicator is up 3 48 to 4 820 65 The total Pre Market volume is currently 6 767 304 shares traded The following are the most active stocks for the pre market session Rice Energy Inc RICE is 1 9 at 25 24 with 1 781 561 shares traded
ARRY,ARRY:US,BBG000C52TW3,"Top Analyst Upgrades and Downgrades: CBOE, Comcast, GW Pharma, Hormel, Vonage, Wells Fargo and Many More",2016-09-27 12:45:04 +0000,http://247wallst.com/investing/2016/09/27/top-analyst-upgrades-and-downgrades-cboe-comcast-gw-pharma-hormel-vonage-wells-fargo-and-many-more/,"Top Analyst Upgrades and Downgrades: CBOE, Comcast, GW Pharma, Hormel, Vonage, Wells Fargo and Many More"
ARRY,ARRY:US,BBG000C52TW3,"ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial",2016-09-27 02:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KUQnhvR44UY/arry-hits-columbus-goals-kite-flies-afterhrs-fda-places-hold-on-cvm-trial-20160927-00041,"ARRY Hits COLUMBUS Goals, KITE Flies After-hrs, FDA Places Hold On CVM Trial"
ARRY,ARRY:US,BBG000C52TW3,"Why Array Biopharma Inc (ARRY), Sally Beauty Holdings, Inc. (SBH) and Twitter Inc (TWTR) Are 3 of Today’s Best Stocks",2016-09-26 23:21:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7MbXRMYzOuc/why-array-biopharma-inc-arry-sally-beauty-holdings-inc-sbh-and-twitter-inc-twtr-are-3-of-todays-best-stocks-cm684894,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Perhaps displaying a case of nerves ahead of the first presidential debate between Democratic nominee Hillary Clinton and Republican nominee Donald Trump investors sold equities
ARRY,ARRY:US,BBG000C52TW3,"Why Array BioPharma, Chemtura, and GW Pharmaceuticals Jumped Today",2016-09-26 23:21:06 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D7B8pfwnyZc/why-array-biopharma-chemtura-and-gw-pharmaceuticals-jumped-today-cm684892,Image source Getty Images Volatility is returning to the stock market and investors felt the downward side of that equation on Monday Major market benchmarks fell as much as 1 as investors tried to prepare for the first U S Presidential debate tonight Although few
ARRY,ARRY:US,BBG000C52TW3,"Why Array BioPharma, Chemtura, and GW Pharmaceuticals Jumped Today",2016-09-26 22:03:00 +0000,http://www.fool.com/investing/2016/09/26/why-array-biopharma-chemtura-and-gw-pharmaceutical.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Array BioPharma, Chemtura, and GW Pharmaceuticals Jumped Today"
ARRY,ARRY:US,BBG000C52TW3,"Health Care Sector Update for 09/26/2016: MSON,ARRY,PTIE",2016-09-26 20:21:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_eHxDhansUc/health-care-sector-update-for-09262016-msonarryptie-cm684816,Top Health Care StocksTop Health Care Stocks JNJ 0 8 JNJ 0 8 PFE 1 7 PFE 1 7 MRK 1 4 MRK 1 4 ABT 1 4 ABT 1 4 AMGN 0 7 AMGN 0 7 Health care stocks were sinking Monday afternoon with the NYSE Health Care Index NYP falling about 1 2 while shares of health care companies in
ARRY,ARRY:US,BBG000C52TW3,Mid-Afternoon Market Update: Dow Falls 150 Points; Himax Technologies Shares Slide After Nomura Downgrade,2016-09-26 19:46:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XSipKP2n1X0/mid-afternoon-market-update-dow-falls-150-points-himax-technologies-shares-slide-after-nomura-downgrade-cm684813,Toward the end of trading Monday the Dow traded down 0 83 percent to 18 109 35 while the NASDAQ declined 0 88 percent to 5 258 98 The S amp P also fell dropping 0 79 percent to 2 147 64 Leading and Lagging Sectors Monday afternoon energy shares slipped by just 0 1
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Inc (ARRY) Surges 60% as Shorts Get Squeezed,2016-09-26 19:22:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1ccGt4mi0bg/array-biopharma-inc-arry-surges-60-as-shorts-get-squeezed-cm684751,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Array Biopharma Inc 160 NASDAQ ARRY is one of the few stocks moving anywhere Monday as the markets await the first presidential debate between Hillary Clinton and
ARRY,ARRY:US,BBG000C52TW3,Mid-Day Market Update: Crude Oil Up 3.3%; Chemtura Shares Surge Following Acquisition News,2016-09-26 18:16:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZVuWRW5lDQM/mid-day-market-update-crude-oil-up-33-chemtura-shares-surge-following-acquisition-news-cm684715,Midway through trading Monday the Dow traded down 0 79 percent to 18 116 61 while the NASDAQ declined 0 79 percent to 5 264 04 The S amp P also fell dropping 0 69 percent to 2 149 82 Leading and Lagging Sectors On Monday basic materials shares rose 0 06 percent Meanwhile
ARRY,ARRY:US,BBG000C52TW3,"Health Care Sector Update for 09/26/2016: GLPG,ARRY,PTIE",2016-09-26 18:01:03 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zJAwv4ui3Ck/health-care-sector-update-for-09262016-glpgarryptie-cm684712,Top Health Care StocksTop Health Care Stocks JNJ 0 93 JNJ 0 93 PFE 1 78 PFE 1 78 MRK 1 20 MRK 1 20 ABT 1 50 ABT 1 50 AMGN 0 91 AMGN 0 91 Health care stocks were sinking Monday afternoon with the NYSE Health Care Index falling about 1 1 while shares of health care companies in
ARRY,ARRY:US,BBG000C52TW3,"Midday Update: Wall Street Remains Defensive on Banking Sector Losses, Ahead of Presidential Debate",2016-09-26 17:01:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/j6hoF774S9M/midday-update-wall-street-remains-defensive-on-banking-sector-losses-ahead-of-presidential-debate-cm684664,Shares were lower for a second straight day on Monday disregarding a rally in oil futures as banking stocks tumbled in sympathy with Deutsche Bank DB and Wall Street braced for tonight s presidential debate between Republican candidate Donald Trump and Democratic candidate
ARRY,ARRY:US,BBG000C52TW3,"Why Investors Are Buzzing About Yum, Twitter, GM, RetailMeNot, and Array Biopharma Today",2016-09-26 16:49:49 +0000,http://www.insidermonkey.com/blog/why-investors-are-buzzing-about-yum-twitter-gm-retailmenot-and-array-biopharma-today-476895/,"Why Investors Are Buzzing About Yum, Twitter, GM, RetailMeNot, and Array Biopharma Today"
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Inc Is Surging Today,2016-09-26 16:11:43 +0000,http://www.fool.com/investing/2016/09/26/duplicatedaily-10er-hit-duplicate.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Array BioPharma Inc Is Surging Today
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Shares Soar on Melanoma Trial’s Early Results,2016-09-26 16:10:10 +0000,http://finance.yahoo.com/news/array-biopharma-shares-soar-melanoma-161010590.html,Array Biopharma Shares Soar on Melanoma Trial’s Early Results
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma (ARRY) Stock Soars on Drug Success, Piper Jaffray Ups Price Target",2016-09-26 15:50:00 +0000,https://www.thestreet.com/story/13751828/1/array-biopharma-arry-stock-soars-on-drug-success-piper-jaffray-ups-price-target.html?puc=yahoo&cm_ven=YAHOO,"Array BioPharma (ARRY) Stock Soars on Drug Success, Piper Jaffray Ups Price Target"
ARRY,ARRY:US,BBG000C52TW3,Mid-Morning Market Update: Markets Open Lower; Cal-Maine Posts Wider-Than-Expected Loss,2016-09-26 15:11:27 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/b4lkFj-IVxc/mid-morning-market-update-markets-open-lower-cal-maine-posts-wider-than-expected-loss-cm684495,Following the market opening Monday the Dow traded down 0 77 percent to 18 120 00 while the NASDAQ declined 0 76 percent to 5 265 61 The S amp P also fell dropping 0 65 percent to 2 150 56 Leading and Lagging Sectors Monday morning basic materials shares rose 0 10
ARRY,ARRY:US,BBG000C52TW3,4 Biopharma Companies Moving on Monday Ahead of the Presidential Debate,2016-09-26 14:15:44 +0000,http://247wallst.com/healthcare-business/2016/09/26/4-biopharma-companies-moving-on-monday-ahead-of-the-presidential-debate/,4 Biopharma Companies Moving on Monday Ahead of the Presidential Debate
ARRY,ARRY:US,BBG000C52TW3,"Stocks to Watch: Chemtura, Deutsche Bank, Array BioPharma",2016-09-26 13:20:44 +0000,http://blogs.wsj.com/moneybeat/2016/09/26/stocks-to-watch-chemtura-deutsche-bank-array-biopharma/?mod=yahoo_hs,"Stocks to Watch: Chemtura, Deutsche Bank, Array BioPharma"
ARRY,ARRY:US,BBG000C52TW3,"Pre-Market Most Active for Sep 26, 2016 :  TWTR, DB, ARRY, CHMT, AZN, LYG, HSBC, AAPL, NVAX, XIV, QQQ, TVIX",2016-09-26 13:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ezd1kd7wtWw/pre-market-most-active-for-sep-26-2016-twtr-db-arry-chmt-azn-lyg-hsbc-aapl-nvax-xiv-qqq-tvix-cm684362,The NASDAQ 100 Pre Market Indicator is down 11 43 to 4 847 48 The total Pre Market volume is currently 5 973 698 shares traded The following are the most active stocks for the pre market session Twitter Inc TWTR is 0 75 at 21 87 with 931 457 shares traded TWTR
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Inc Conference Call regarding Phase 3 COLUMBUS study scheduled for 9:00 am ET today,2016-09-26 13:00:00 +0000,http://biz.yahoo.com/cc/4/153844.html,Array Biopharma Inc Conference Call regarding Phase 3 COLUMBUS study scheduled for 9:00 am ET today
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma and Pierre Fabre Announce COLUMBUS Phase 3 Study of Encorafenib plus Binimetinib For BRAF-Mutant Melanoma Met Primary Endpoint,2016-09-26 11:19:06 +0000,http://www.publicnow.com/view/2C702A6E4E5484D5160238561F26BFC70402309D,"[at noodls] - BOULDER, Colo., Sept. 26, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) and Pierre Fabre today jointly announced top-line results from Part 1 of the Phase 3 COLUMBUS (Combined LGX818 Used with MEK162 ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-09-26 11:02:39 +0000,http://biz.yahoo.com/e/160926/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
ARRY,ARRY:US,BBG000C52TW3,"Array,Pierre Fabre Report COLUMBUS Phase 3 Study Of Encorafenib Plus Binimetinib",2016-09-26 07:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0Hc7WybSbnw/arraypierre-fabre-report-columbus-phase-3-study-of-encorafenib-plus-binimetinib-20160926-00260,"Array,Pierre Fabre Report COLUMBUS Phase 3 Study Of Encorafenib Plus Binimetinib"
ARRY,ARRY:US,BBG000C52TW3,"Array,Pierre Fabre Report COLUMBUS Phase 3 Study Of Encorafenib Plus Binimetinib",2016-09-26 07:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BmR0HFNHrCM/arraypierre-fabre-report-columbus-phase-3-study-of-encorafenib-plus-binimetinib-20160926-00261,"Array,Pierre Fabre Report COLUMBUS Phase 3 Study Of Encorafenib Plus Binimetinib"
ARRY,ARRY:US,BBG000C52TW3,3 Biotechs That Could Be M&A Targets,2016-09-24 17:20:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NmRMs_S2siU/3-biotechs-that-could-be-ma-targets-cm684176,Image source Getty Images After Pfizer Inc agreed to pay 14 times forecast sales for 2016 160 to acquire cancer drugmaking pure play Medivation last month shares in other cancer focused biotech companies shot higher While it doesn t make sense to buy shares in all
ARRY,ARRY:US,BBG000C52TW3,3 Biotechs That Could Be M&A Targets,2016-09-24 16:09:27 +0000,http://www.fool.com/investing/2016/09/24/3-biotechs-that-could-be-ma-targets.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Biotechs That Could Be M&A Targets
ARRY,ARRY:US,BBG000C52TW3,5 Stocks Insiders Love Right Now,2016-09-21 17:38:00 +0000,https://www.thestreet.com/story/13747715/1/5-stocks-insiders-love-right-now.html?puc=yahoo&cm_ven=YAHOO,5 Stocks Insiders Love Right Now
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. – Value Analysis (NASDAQ:ARRY) : September 21, 2016",2016-09-21 15:23:11 +0000,http://www.capitalcube.com/blog/index.php/array-biopharma-inc-value-analysis-nasdaqarry-september-21-2016/,"Array BioPharma, Inc. – Value Analysis (NASDAQ:ARRY) : September 21, 2016"
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 20, 2016",2016-09-20 12:13:32 +0000,http://www.capitalcube.com/blog/index.php/array-biopharma-inc-breached-its-50-day-moving-average-in-a-bullish-manner-arry-us-september-20-2016/,"Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 20, 2016"
ARRY,ARRY:US,BBG000C52TW3,Do You Have These Biotech Stocks In Your Portfolio?,2016-09-19 14:13:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_61YoYvqeDo/do-you-have-these-biotech-stocks-in-your-portfolio-20160919-00807,Do You Have These Biotech Stocks In Your Portfolio?
ARRY,ARRY:US,BBG000C52TW3,10 Analyst Stock Picks Under $10 for Massive Upside,2016-09-18 14:15:15 +0000,http://247wallst.com/investing/2016/09/18/10-analyst-stock-picks-under-10-for-massive-upside/,10 Analyst Stock Picks Under $10 for Massive Upside
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference,2016-09-17 09:38:06 +0000,http://www.publicnow.com/view/EAD7184608B6DF4DB76FE70CFF439C24C3057D69,"[at noodls] - BOULDER, Colo., Sept. 6, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2016 Morgan Stanley Global Healthcare ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma,2016-09-17 09:18:05 +0000,http://www.publicnow.com/view/297F8AF2B745982643C16FE97E8365DDF815790C,"[at noodls] - BOULDER, Colo., Sept. 1, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) today announced that the FDA has accepted its New Drug Application (NDA) for binimetinib with a target action date under the ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference,2016-09-17 09:18:05 +0000,http://www.publicnow.com/view/E0503A9216F2DD5A9A0C436C4F336C9F2C503F95,"[at noodls] - BOULDER, Colo., Aug. 31, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference ..."
ARRY,ARRY:US,BBG000C52TW3,Array Secures SPA Agreement With FDA for Colorectal Cancer Trial (ARRY),2016-09-15 00:25:00 +0000,http://www.investopedia.com/news/array-secures-spa-agreement-fda-colorectal-cancer-trial-arry/?partner=YahooSA,Array Secures SPA Agreement With FDA for Colorectal Cancer Trial (ARRY)
ARRY,ARRY:US,BBG000C52TW3,"Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today",2016-09-14 16:08:15 +0000,http://www.insidermonkey.com/blog/why-sarepta-glu-mobile-harmony-gold-and-2-other-stocks-are-on-the-move-today-474605/,"Why Sarepta, Glu Mobile, Harmony Gold and 2 Other Stocks Are On The Move Today"
ARRY,ARRY:US,BBG000C52TW3,Key FDA Decisions and Trial Results Coming in the Next 2 Months,2016-09-14 12:20:11 +0000,http://247wallst.com/healthcare-business/2016/09/14/key-fda-decisions-and-trial-results-coming-in-the-next-2-months/,Key FDA Decisions and Trial Results Coming in the Next 2 Months
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Phase 3 BEACON CRC SPA Agreement with FDA,2016-09-14 11:48:07 +0000,http://www.publicnow.com/view/83616103A34DA18A474FFB930443E87DE8C9EAE2,"[at noodls] - BOULDER, Colo., Sept. 14, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) regarding a Special Protocol ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-09-14 11:33:04 +0000,http://biz.yahoo.com/e/160914/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
ARRY,ARRY:US,BBG000C52TW3,Stryker To Present At Morgan Stanley Global Conference; Webcast At 8:45 AM ET,2016-09-14 07:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zivmY_w-NHM/stryker-to-present-at-morgan-stanley-global-conference-webcast-at-845-am-et-20160914-00286,Stryker To Present At Morgan Stanley Global Conference; Webcast At 8:45 AM ET
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At Morgan Stanley Conference; Webcast At 8:45 AM ET,2016-09-14 07:45:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/heQShJ7oIgM/array-biopharma-to-present-at-morgan-stanley-conference-webcast-at-845-am-et-20160914-00287,Array BioPharma To Present At Morgan Stanley Conference; Webcast At 8:45 AM ET
ARRY,ARRY:US,BBG000C52TW3,Why Array Biopharma May Become a Winner (ARRY),2016-09-12 17:55:00 +0000,http://www.investopedia.com/news/why-array-biopharma-may-become-winner-arry/?partner=YahooSA,Why Array Biopharma May Become a Winner (ARRY)
ARRY,ARRY:US,BBG000C52TW3,How To Approach Momentum Trading Like A Pro,2016-09-11 20:00:04 +0000,http://www.investopedia.com/articles/active-trading/021815/importance-managing-risk-momentum-markets.asp?rp=y&partner=YahooSA,[at Investopedia] - Momentum markets generate high-reward high-risk environments that confound traders until they employ specific risk management practices.
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 9, 2016",2016-09-09 12:12:46 +0000,http://www.capitalcube.com/blog/index.php/array-biopharma-inc-breached-its-50-day-moving-average-in-a-bullish-manner-arry-us-september-9-2016/,"Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : September 9, 2016"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Participate In Wells Fargo Healthcare Conference At 9:50 AM,2016-09-07 08:52:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/tpK2QM0FtCo/array-biopharma-to-participate-in-wells-fargo-healthcare-conference-at-950-am-20160907-00540,Array BioPharma To Participate In Wells Fargo Healthcare Conference At 9:50 AM
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Morgan Stanley Global Healthcare Conference,2016-09-06 15:29:02 +0000,http://www.publicnow.com/view/34B4F280DF14BFB09F1FEEFC1DF29D770F5CB9B2,"[at noodls] - BOULDER, Colo., Sept. 6, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2016 Morgan Stanley Global Healthcare ..."
ARRY,ARRY:US,BBG000C52TW3,5 Speculative Biotech Analyst Stocks Under $10 With Massive Upside,2016-09-04 14:40:44 +0000,http://247wallst.com/healthcare-business/2016/09/04/5-speculative-biotech-analyst-stocks-under-10-with-massive-upside/,5 Speculative Biotech Analyst Stocks Under $10 With Massive Upside
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob",2016-09-02 20:19:37 +0000,http://biz.yahoo.com/e/160902/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial Ob"
ARRY,ARRY:US,BBG000C52TW3,What Are Array Biopharma Inc (ARRY)’s Chances Of PDUFA Success?,2016-09-02 18:33:58 +0000,http://www.insidermonkey.com/blog/what-are-array-biopharma-inc-arrys-chances-of-pdufa-success-472106/,What Are Array Biopharma Inc (ARRY)’s Chances Of PDUFA Success?
ARRY,ARRY:US,BBG000C52TW3,Array (ARRY) Oncology Drug Accepted for Review in the U.S.,2016-09-02 15:22:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sQUdwgmSqHM/array-arry-oncology-drug-accepted-for-review-in-the-us-cm674007,Array BioPharma ARRY announced that the FDA has accepted a New Drug Application NDA for its pipeline candidate binimetinib The NDA was submitted in Jun 2016 based on positive results from the phase III trial NEMO which compared binimetinib with dacarbazine in unresectable or
ARRY,ARRY:US,BBG000C52TW3,Array (ARRY) Oncology Drug Accepted for Review in the U.S.,2016-09-02 13:29:01 +0000,http://finance.yahoo.com/news/array-arry-oncology-drug-accepted-132901453.html,Array (ARRY) Oncology Drug Accepted for Review in the U.S.
ARRY,ARRY:US,BBG000C52TW3,8 Major FDA Decisions and Trial Results to Watch for in September,2016-09-02 11:40:11 +0000,http://247wallst.com/healthcare-business/2016/09/02/8-major-fda-decisions-and-trial-results-to-watch-for-in-september/,8 Major FDA Decisions and Trial Results to Watch for in September
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma,2016-09-01 12:23:06 +0000,http://www.publicnow.com/view/240880723E5EE020C271725BDD0273000D489614,"[at noodls] - BOULDER, Colo., Sept. 1, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) today announced that the FDA has accepted its New Drug Application (NDA) for binimetinib with a target action date under the ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-09-01 12:04:21 +0000,http://biz.yahoo.com/e/160901/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces FDA Acceptance of Binimetinib NDA for Patients with Advanced NRAS-Mutant Melanoma,2016-09-01 12:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-announces-fda-acceptance-120000931.html,"[PR Newswire] - BOULDER, Colo., Sept. 1, 2016 /PRNewswire/ -- Array BioPharma (ARRY) today announced that the FDA has accepted its New Drug Application (NDA) for binimetinib with a target action date under the Prescription Drug User Fee Act (PDUFA) of June 30, 2017. Array completed its NDA submission of binimetinib in late June 2016 based on findings from the pivotal Phase 3 NEMO (NRAS MELANOMA AND MEK INHIBITOR) trial in patients with NRAS-mutant melanoma. The FDA also indicated that it plans to hold an advisory committee meeting (ODAC) as part of the review process. As previously reported, Array is currently preparing for an Application Orientation Meeting (AOM) with the FDA in September 2016, which it expects will include a discussion of the NDA package including clinical risk / benefit."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Says FDA Accepts Binimetinib NDA,2016-09-01 08:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/D3ieewqk22w/array-biopharma-says-fda-accepts-binimetinib-nda-20160901-00388,Array BioPharma Says FDA Accepts Binimetinib NDA
ARRY,ARRY:US,BBG000C52TW3,Array (ARRY) Presents Positive Cardiovascular Trial Data,2016-08-31 17:12:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JTF5Gej1NXE/array-arry-presents-positive-cardiovascular-trial-data-cm672940,"Array BioPharmaARRY presented results from a phase II study on its pipeline candidate, ARRY 797, at the European Society of Cardiology Congress 2016 in Rome, Italy.  ARRY 797 is an oral, selective p38 mitogen activated protein"
ARRY,ARRY:US,BBG000C52TW3,Array (ARRY) Presents Positive Cardiovascular Trial Data,2016-08-31 15:28:03 +0000,http://finance.yahoo.com/news/array-arry-presents-positive-cardiovascular-152803482.html,Array (ARRY) Presents Positive Cardiovascular Trial Data
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference,2016-08-31 13:23:04 +0000,http://www.publicnow.com/view/08E9E8D53DF8C01701E12682EDE5AE2493787DBB,"[at noodls] - BOULDER, Colo., Aug. 31, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Wells Fargo Securities Healthcare Conference,2016-08-31 13:00:00 +0000,http://finance.yahoo.com/news/array-biopharma-present-wells-fargo-130000230.html,"[PR Newswire] - BOULDER, Colo., Aug. 31, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Healthcare Conference ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Continues Its Silent Rally With Mid-Stage Trial Win,2016-08-30 16:20:37 +0000,http://247wallst.com/healthcare-business/2016/08/30/array-biopharma-continues-its-silent-rally-with-mid-stage-trial-win/,Array BioPharma Continues Its Silent Rally With Mid-Stage Trial Win
ARRY,ARRY:US,BBG000C52TW3,"Pre-Market Most Active for Aug 30, 2016 :  RIGL, AZN, AAPL, LYG, MT, ANF, RDS/B, DSW, ARRY, GIII, SPU, GOLD",2016-08-30 12:56:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1RES50Exsjc/pre-market-most-active-for-aug-30-2016-rigl-azn-aapl-lyg-mt-anf-rdsb-dsw-arry-giii-spu-gold-cm672036,"The NASDAQ 100 Pre Market Indicator is down 5.29 to 4,785.8. The total Pre Market volume is currently 4,001,481 shares traded. The following are the most active stocks for the pre market session Rigel Pharmaceuticals, Inc. ( RIGL )"
ARRY,ARRY:US,BBG000C52TW3,Array Presents Data from Cardiovascular Trial with ARRY-797 at the European Society of Cardiology Congress,2016-08-30 12:13:01 +0000,http://www.publicnow.com/view/F15D89ABFD91633298A5E659D745657AF759DE18,"[at noodls] - BOULDER, Colo., Aug. 30, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) announced today results from a Phase 2 study of ARRY-797, an oral, selective p38 mitogen-activated protein kinase inhibitor, ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-08-30 12:02:48 +0000,http://biz.yahoo.com/e/160830/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma: ARRY-797 Trial Data Shows Promising Clinical Activity,2016-08-30 08:18:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/eVpk_I86ACA/array-biopharma-arry797-trial-data-shows-promising-clinical-activity-20160830-00310,Array BioPharma: ARRY-797 Trial Data Shows Promising Clinical Activity
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma (ARRY) Stock Advances, Price Target Raised at Jefferies",2016-08-29 19:51:00 +0000,https://www.thestreet.com/story/13688186/1/array-biopharma-arry-stock-advances-price-target-raised-at-jefferies.html?puc=yahoo&cm_ven=YAHOO,"Array BioPharma (ARRY) Stock Advances, Price Target Raised at Jefferies"
ARRY,ARRY:US,BBG000C52TW3,"Top Analyst Upgrades and Downgrades: Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square, T-Mobile and More",2016-08-29 12:55:48 +0000,http://247wallst.com/investing/2016/08/29/top-analyst-upgrades-and-downgrades-harley-davidson-hp-keycorp-kla-tencor-netflix-square-t-mobile-and-more/,"Top Analyst Upgrades and Downgrades: Harley-Davidson, HP, KeyCorp, KLA-Tencor, Netflix, Square, T-Mobile and More"
ARRY,ARRY:US,BBG000C52TW3,"ETF’s with exposure to Array BioPharma, Inc. : August 23, 2016",2016-08-23 15:20:55 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-array-biopharma-inc-august-23-2016/,"ETF’s with exposure to Array BioPharma, Inc. : August 23, 2016"
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016",2016-08-22 13:40:48 +0000,http://www.capitalcube.com/blog/index.php/array-biopharma-inc-arry-us-earnings-analysis-2016-by-the-numbers-august-22-2016/,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: 2016 By the Numbers : August 22, 2016"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Clinical Data Presentation On ARRY-797 At The 2016 European Society Of Cardiology Congress,2016-08-19 19:51:01 +0000,http://www.publicnow.com/view/55839A5F5A374C616FC751F3D2154495FC924160,"[at noodls] - BOULDER, Colo., Aug. 19, 2016 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced that results from a Phase 2 study of ARRY-797 will be presented at the 2016 European Society of Cardiology ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report",2016-08-19 12:32:42 +0000,http://biz.yahoo.com/e/160819/arry10-k.html,"ARRAY BIOPHARMA INC Files SEC form 10-K, Annual Report"
ARRY,ARRY:US,BBG000C52TW3,"ETF’s with exposure to Array BioPharma, Inc. : August 11, 2016",2016-08-11 16:31:10 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-array-biopharma-inc-august-11-2016/,"ETF’s with exposure to Array BioPharma, Inc. : August 11, 2016"
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q4, 2016 By the Numbers : August 10, 2016",2016-08-10 16:54:11 +0000,http://www.capitalcube.com/blog/index.php/array-biopharma-inc-arry-us-earnings-analysis-q4-2016-by-the-numbers-august-10-2016/,"Array BioPharma, Inc. :ARRY-US: Earnings Analysis: Q4, 2016 By the Numbers : August 10, 2016"
ARRY,ARRY:US,BBG000C52TW3,Shareholder Alert: Purcell Julie & Lefkowitz LLP Is Investigating Array BioPharma Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors,2016-08-10 14:55:00 +0000,http://finance.yahoo.com/news/shareholder-alert-purcell-julie-lefkowitz-145500461.html,"[PR Newswire] - NEW YORK, Aug. 10, 2016 /PRNewswire/ -- Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim ..."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : August 10, 2016",2016-08-10 12:14:13 +0000,http://www.capitalcube.com/blog/index.php/array-biopharma-inc-breached-its-50-day-moving-average-in-a-bearish-manner-arry-us-august-10-2016/,"Array BioPharma, Inc. breached its 50 day moving average in a Bearish Manner : ARRY-US : August 10, 2016"
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma Inc. Is Plunging Today,2016-08-09 20:56:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vgcIGwoPAHA/why-array-biopharma-inc-is-plunging-today-cm662838,"Image source  Getty Images.  What  Shares of Array BioPharma (NASDAQ  ARRY) , a cancer focused clinical stage biotech, are down more than 22% as of 1 30 p.m. EDT today. The reason is"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial,2016-08-09 19:37:00 +0000,https://www.thestreet.com/story/13670102/1/array-biopharma-arry-stock-drops-on-failed-lung-cancer-drug-trial.html?puc=yahoo&cm_ven=YAHOO,Array BioPharma (ARRY) Stock Drops on Failed Lung Cancer Drug Trial
ARRY,ARRY:US,BBG000C52TW3,3 Biotech Stocks With Catalysts That Have 90% to 500% Upside Potential,2016-08-09 15:05:44 +0000,http://247wallst.com/healthcare-business/2016/08/09/3-biotech-stocks-with-catalysts-that-have-90-to-500-upside-potential/,3 Biotech Stocks With Catalysts That Have 90% to 500% Upside Potential
ARRY,ARRY:US,BBG000C52TW3,"Pre-Market Most Active for Aug 9, 2016 :  MWW, VRX, NVO, CHL, AZN, HIIQ, SM, ARRY, YHOO, ENDP, AAPL, XIV",2016-08-09 12:57:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/B2Lj3Nn3FBU/pre-market-most-active-for-aug-9-2016-mww-vrx-nvo-chl-azn-hiiq-sm-arry-yhoo-endp-aapl-xiv-cm662321,"The NASDAQ 100 Pre Market Indicator is up 1.31 to 4,786.05. The total Pre Market volume is currently 22,955,935 shares traded. The following are the most active stocks for the pre market session Monster Worldwide, Inc. ( MWW )"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma shares fall 11% premarket after lung cancer drug trial fails to meet goals,2016-08-09 11:40:43 +0000,http://www.marketwatch.com/News/Story/Story.aspx?guid=FBE249C6-710D-4F81-9414-07D385ECA6D6&siteid=yhoof2,Array BioPharma shares fall 11% premarket after lung cancer drug trial fails to meet goals
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits",2016-08-09 10:10:59 +0000,http://biz.yahoo.com/e/160809/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits"
ARRY,ARRY:US,BBG000C52TW3,AstraZeneca Provides Update On Phase III Trial Of Selumetinib In Non-Small Cell Lung Cancer,2016-08-09 06:20:06 +0000,http://www.publicnow.com/view/639787BF9E7621117CC0EB1318E406BBD2185CDC,"[at noodls] - BOULDER, Colo., Aug. 9, 2016 /PRNewswire/ -- AstraZeneca (LON/STO/NYSE: AZN) today announced results from the Phase III SELECT-1 trial of the MEK 1/2 inhibitor, selumetinib, in combination with docetaxel ..."
ARRY,ARRY:US,BBG000C52TW3,AstraZeneca: Selumetinib Fails To Meet Trial Endpoint In KRASm NSCLC Patients,2016-08-09 02:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/a3p7NCFfYYk/astrazeneca-selumetinib-fails-to-meet-trial-endpoint-in-krasm-nsclc-patients-20160809-00026,AstraZeneca: Selumetinib Fails To Meet Trial Endpoint In KRASm NSCLC Patients
ARRY,ARRY:US,BBG000C52TW3,Edited Transcript of ARRY earnings conference call or presentation 4-Aug-16 1:00pm GMT,2016-08-05 19:00:02 +0000,http://finance.yahoo.com/news/edited-transcript-arry-earnings-conference-190002930.html,Edited Transcript of ARRY earnings conference call or presentation 4-Aug-16 1:00pm GMT
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) in Focus: Stock Moves 9.3% Higher,2016-08-05 13:58:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XYTCZoKcSm8/array-biopharma-arry-in-focus-stock-moves-93-higher-cm661099,"Array BioPharma Inc.ARRY was a big mover last session, as its shares rose over 9% on the day. The upside was driven by the company's revenue beat in the fourth quarter of fiscal 2016. This led to far more"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) in Focus: Stock Moves 9.3% Higher,2016-08-05 12:25:12 +0000,http://finance.yahoo.com/news/array-biopharma-arry-focus-stock-122512718.html,Array BioPharma (ARRY) in Focus: Stock Moves 9.3% Higher
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma reports 4Q loss,2016-08-04 13:11:24 +0000,http://sg.finance.yahoo.com/news/array-biopharma-reports-4q-loss-131124519.html,Array BioPharma reports 4Q loss
ARRY,ARRY:US,BBG000C52TW3,Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today,2016-08-04 13:00:00 +0000,http://biz.yahoo.com/cc/0/153220.html,Array Biopharma Inc Earnings Call scheduled for 9:00 am ET today
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Reports Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016,2016-08-04 12:12:05 +0000,http://www.publicnow.com/view/CFF9D659BCB35941E6506C1F58C343E2EC41890B,"[at noodls] - BOULDER, Colo., Aug. 4, 2016 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule cancer ..."
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib",2016-08-04 12:03:21 +0000,http://biz.yahoo.com/e/160804/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib"
ARRY,ARRY:US,BBG000C52TW3,Q4 2016 Array Biopharma Inc Earnings Release - Before Market Open,2016-08-04 11:07:02 +0000,http://biz.yahoo.com/research/earncal/20160804.html?t=arry,Q4 2016 Array Biopharma Inc Earnings Release - Before Market Open
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Q4 16 Earnings Conference Call At 9:00 AM ET,2016-08-04 08:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uQZb_ELCpj4/array-biopharma-q4-16-earnings-conference-call-at-900-am-et-20160804-00562,Array BioPharma Q4 16 Earnings Conference Call At 9:00 AM ET
ARRY,ARRY:US,BBG000C52TW3,"ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits",2016-08-03 21:05:29 +0000,http://biz.yahoo.com/e/160803/arry8-k.html,"ARRAY BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits"
ARRY,ARRY:US,BBG000C52TW3,"Monday's ETF Movers: XBI, OIH",2016-08-01 20:52:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/njYT0QkLPmg/mondays-etf-movers-xbi-oih-cm658376,"In trading on Monday, the SPDR S&P Biotech ETF ( XBI ) is outperforming other ETFs, up about 2.6% on the day. Components of that ETF showing particular strength include shares of Ionis Pharmaceuticals ( IONS ), up about"
ARRY,ARRY:US,BBG000C52TW3,Mid-Afternoon Market Update: Trina Solar Gains Following Go-Private Deal; Insperity Shares Drop,2016-08-01 20:18:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/th4lrqR-SMg/mid-afternoon-market-update-trina-solar-gains-following-go-private-deal-insperity-shares-drop-cm658390,"Toward the end of trading Monday, the Dow traded down 0.21 percent to 18,392.76 while the NASDAQ gained 0.40 percent to 5,182.87. The S&P also fell, dropping 0.16 percent to 2,170.12.  Leading and Lagging"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Appointment Of Jason Haddock As Chief Financial Officer,2016-07-28 12:18:07 +0000,http://www.publicnow.com/view/30FDDFC6069AC15FB5D87E03B641D273B4083404,"[at noodls] - BOULDER, Colo., July 28, 2016 /PRNewswire/ -- Array BioPharma (NASDAQ: ARRY) ('Array'), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule ..."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2016 On August 4, 2016",2016-07-27 21:18:06 +0000,http://www.publicnow.com/view/D39E020A42E50FE1B55932FE1C7427146BD45AA6,"[at noodls] - BOULDER, Colo., July 27, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the fourth quarter and full year of fiscal 2016 and hold a conference call to discuss ..."
ARRY,ARRY:US,BBG000C52TW3,CA Technologies Appoints Kieran McGrath As Interim CFO - Quick Facts,2016-07-27 16:56:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pSePQhvSPpY/ca-technologies-appoints-kieran-mcgrath-as-interim-cfo--quick-facts-20160727-01475,CA Technologies Appoints Kieran McGrath As Interim CFO - Quick Facts
ARRY,ARRY:US,BBG000C52TW3,Top-Rated Stock Picks and Popular Stories on Nasdaq.com: July 17 - 23,2016-07-26 15:04:28 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fkrdGnxg-2o/top-rated-stock-picks-and-popular-stories-on-nasdaqcom-july-17-23-cm654871,Welcome to the latest installment of community stock picks and overview of some of the most-read stories of the week. We're taking a look at stocks chosen by members of the Nasdaq.com community from July 17 - 23.   Bullish Stocks: Here's What You Said:    Alphabet ( GOOGL ): Probably the best growth stock in the
ARRY,ARRY:US,BBG000C52TW3,"Biotech Equities Technical Briefing on Array BioPharma, Geron, Emergent BioSolutions, and Global Blood Therapeutics",2016-07-18 13:32:12 +0000,http://news.investornetwork.com/2016/07/18/biotech-equities-technical-briefing-on-array-biopharma-geron-emergent-biosolutions-and-global-blood-therapeutics/?1=1&1468848732,"Biotech Equities Technical Briefing on Array BioPharma, Geron, Emergent BioSolutions, and Global Blood Therapeutics"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Cantor Fitzgerald 2nd Annual Healthcare Conference,2016-07-07 22:36:00 +0000,http://finance.yahoo.com/news/array-biopharma-present-cantor-fitzgerald-223600727.html,"[PR Newswire] - BOULDER, Colo., July 7, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Cantor Fitzgerald 2 nd Annual Healthcare ..."
ARRY,ARRY:US,BBG000C52TW3,"Health Care Sector Update for 07/01/2016: MRK,ARRY,MSLI",2016-07-01 20:23:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y9S9VtHYbPc/health-care-sector-update-for-07012016-mrkarrymsli-cm644044,"Top Health Care Stocks JNJ 0.05% PFE +1.04% MRK +0.42% ABT +0.64% AMGN +1.43% Health care stocks were mostly higher ahead of the long holiday weekend, with the NYSE Health Care Index adding about 0.3% while shares of health"
ARRY,ARRY:US,BBG000C52TW3,"Health Care Sector Update for 07/01/2016: ARNA,ARRY,MSLI",2016-07-01 18:46:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8w2vu2DBSKs/health-care-sector-update-for-07012016-arnaarrymsli-cm643997,"Top Health Care Stocks JNJ 0.04% PFE +1.07% MRK +0.25% ABT +0.58% AMGN +1.51% Health care stocks remained higher this afternoon, with the NYSE Health Care Index adding about 0.2% while shares of health care companies in the S&P"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Pulls Back Off Best Levels But Remains Firmly Positive,2016-07-01 13:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pMhqGomBDn4/array-biopharma-pulls-back-off-best-levels-but-remains-firmly-positive-20160701-00532,Array BioPharma Pulls Back Off Best Levels But Remains Firmly Positive
ARRY,ARRY:US,BBG000C52TW3,Stocks Give Back Ground But Remain Mostly Positive - U.S. Commentary,2016-07-01 12:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qBAAtH1Tx04/stocks-give-back-ground-but-remain-mostly-positive--us-commentary-20160701-00498,Stocks Give Back Ground But Remain Mostly Positive - U.S. Commentary
ARRY,ARRY:US,BBG000C52TW3,U.S. Hot Stocks: Hot Stocks to Watch,2016-07-01 09:30:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MOsp0zJXjdc/us-hot-stocks-hot-stocks-to-watch-20160701-00359,U.S. Hot Stocks: Hot Stocks to Watch
ARRY,ARRY:US,BBG000C52TW3,Traders May Take A Break Following Recent Volatility - U.S. Commentary,2016-07-01 08:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1KZbU7LMXzM/traders-may-take-a-break-following-recent-volatility--us-commentary-20160701-00291,Traders May Take A Break Following Recent Volatility - U.S. Commentary
ARRY,ARRY:US,BBG000C52TW3,Traders May Take A Break Following Recent Volatility - U.S. Commentary,2016-07-01 08:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rGuAiMmR0PY/traders-may-take-a-break-following-recent-volatility--us-commentary-20160701-00292,Traders May Take A Break Following Recent Volatility - U.S. Commentary
ARRY,ARRY:US,BBG000C52TW3,Here's Why Array Biopharma Inc. Gained 18.1% in May,2016-06-09 16:16:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qEcj6hz2oV4/heres-why-array-biopharma-inc-gained-181-in-may-cm632937,"Image source  Getty Images.  What   Investors in Array BioPharma (NASDAQ  ARRY) , a clinical stage biotechnology company focused on cancer, had a prosperous May. A handful of developments caused the company's stock"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Jefferies Conference; Webcast At 3:30 PM ET,2016-06-09 14:32:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bZuiFJcJDSU/array-biopharma-to-present-at-the-jefferies-conference-webcast-at-330-pm-et-20160609-00774,Array BioPharma To Present At The Jefferies Conference; Webcast At 3:30 PM ET
ARRY,ARRY:US,BBG000C52TW3,Array Presents Full Results from Phase 3 NEMO Study,2016-06-06 18:48:03 +0000,http://www.publicnow.com/view/E8ED8BE3499BE9F9FA91064F49103CA0F247FAFF,"[at noodls] - BOULDER, Colo., June 6, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) announced full results at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago (Abstract No. 9500) ..."
ARRY,ARRY:US,BBG000C52TW3,Encorafenib-based Regimens Provide Improved PFS and OS in Difficult-to-Treat BRAF-Mutant Colorectal Cancer Compared to Historical Benchmarks,2016-06-04 13:08:06 +0000,http://www.publicnow.com/view/267BCA11E727C807F08D419117C8B44CB36C66E2,"[at noodls] - BOULDER, Colo., June 4, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY) announced today updated results from a Phase 2 study of the combination of encorafenib and cetuximab, with or without alpelisib, ..."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma, Pierre Fabre and Merck KGaA, Darmstadt, Germany Announce Phase 3 BEACON CRC Trial",2016-06-04 13:08:06 +0000,http://www.publicnow.com/view/3053DE59DA734D58092D4923B57B7847A6B17426,"[at noodls] - BOULDER, Colo., June 4, 2016 /PRNewswire/ -- Array BioPharma (Nasdaq: ARRY), Pierre Fabre and Merck KGaA, Darmstadt, Germany, today jointly initiated the BEACON CRC (Binimetinib, Encorafenib And Cetuximab ..."
ARRY,ARRY:US,BBG000C52TW3,Merck Partners with Array BioPharma and Pierre Fabre to Initiate BRAF-mutant mCRC Phase III Trial,2016-06-04 13:08:06 +0000,http://www.publicnow.com/view/5DAD727D71022DFEB538B11A3F2EF7E0D9A1E5EA,"[at noodls] - 9a90ac7c-1236-4ee6-bd59-791e6a7a0881.pdf News Release Your Contact Gangolf Schrimpf +49 151 1454 9591 Not intended for UK- or US-based media June 4, 2016 BEACON CRC trial will assess efficacy of... This ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Jefferies 2016 Global Healthcare Conference,2016-06-02 18:45:08 +0000,http://www.publicnow.com/view/DAD8CA1FF3EB99EC5E797C7F1E568F4CD203B219,"[at noodls] - BOULDER, Colo., June 2, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Jefferies 2016 Global Healthcare Conference ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Key Data from NRAS-mutant Melanoma and BRAF-mutant Colorectal Cancer ASCO 2016 Presentations,2016-05-18 22:12:05 +0000,http://www.publicnow.com/view/68DF63D147070CA69A039B5847E6776779B882D7,"[at noodls] - BOULDER, Colo., May 18, 2016 /PRNewswire/ -- Array BioPharma (NASDAQ: ARRY) will present additional data on its late-stage candidates binimetinib and encorafenib in NRAS-mutant melanoma and BRAF-mutant ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Bank of America Merrill Lynch HealthCare Conference,2016-05-05 23:14:10 +0000,http://www.publicnow.com/view/48BE2BD044E810779A5B03ABFB4317B41DCDA251,"[at noodls] - BOULDER, Colo., May 5, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Bank of America Merrill Lynch Healthcare ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma reports 3Q loss,2016-05-03 12:16:21 +0000,http://sg.finance.yahoo.com/news/array-biopharma-reports-3q-loss-121621520.html,Array BioPharma reports 3Q loss
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Reports Financial Results For The Third Quarter Of Fiscal 2016,2016-05-03 12:10:04 +0000,http://www.publicnow.com/view/3F52F78A98E6C134F7BF3A558D3CAF9872ED9B92,"[at noodls] - BOULDER, Colo., May 3, 2016 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule cancer ..."
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma To Report Financial Results For The Third Quarter Of Fiscal 2016 On May 3, 2016",2016-04-26 16:41:37 +0000,http://www.publicnow.com/view/3300F83667D3B53468F6BA8AC5ADA971011A2671,"[at noodls] - BOULDER, Colo., April 26, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) will report financial results for the third quarter of fiscal 2016 and hold a conference call to discuss those results ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Decision To Discontinue MILO Study In Ovarian Cancer,2016-04-01 13:16:13 +0000,http://www.publicnow.com/view/E756E7C7079F1C4A5BFE6D3FCEBBE29429B0D9BE,"[at noodls] - BOULDER, Colo., April 1, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) announced today its decision to discontinue the MILO study, a Phase 3 trial of binimetinib for the treatment of patients ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma And Asahi Kasei Pharma Corporation Announce Development And Commercialization Collaboration For Novel Pain And Inflammation Program,2016-03-31 13:13:27 +0000,http://www.publicnow.com/view/9F2CBE27DCB2CEA89239DF42CFFA489ACC318F4E,"[at noodls] - BOULDER, Colo. and TOKYO, March 31, 2016 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) and Asahi Kasei Pharma Corporation today announced a strategic collaboration to develop and commercialize select ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma reports 2Q loss,2016-02-02 12:30:56 +0000,http://sg.finance.yahoo.com/news/array-biopharma-reports-2q-loss-123056053.html,Array BioPharma reports 2Q loss
ARRY,ARRY:US,BBG000C52TW3,Dana-Farber Cancer Institute's Belfer Center announces Immuno-Oncology research collaboration with Array BioPharma,2016-02-01 17:21:53 +0000,http://www.publicnow.com/view/DE394C780E860FA215A4C749383CB71623FD31B1,"[at noodls] - , /PRNewswire/ -- today announced an immuno-oncology collaboration with potential applicability in a wide range of oncology indications with (NASDAQ: ARRY). ... This is an abstract of the original noodl. ..."
ARRY,ARRY:US,BBG000C52TW3,Exelixis's Cabozantinib Granted Priority Review in the U.S.,2016-01-29 23:18:09 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BFf8LljeFvY/exelixiss-cabozantinib-granted-priority-review-in-the-us-cm572425,"Exelixis, Inc.EXEL announced that the FDA has accepted the company's rolling New Drug Application (NDA) application for cabozantinib for review. Exelixis is looking to get cabozantinib approved for the treatment of patients with advanced renal cell carcinoma (RCC) who"
ARRY,ARRY:US,BBG000C52TW3,Fate (FATE) to Move ProTmune into Phase I/II Study in Mid-16,2016-01-27 21:23:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CTicnEuoJPc/fate-fate-to-move-protmune-into-phase-iii-study-in-mid-16-cm571201,"Fate Therapeutics, Inc.FATE announced that the FDA has cleared its investigational new drug (IND) application for ProTmune. Fate plans to initiate a controlled, randomized multi center phase I II study in adult patients with hematologic"
ARRY,ARRY:US,BBG000C52TW3,"Array BioPharma To Report Financial Results For The Second Quarter Of Fiscal 2016 On February 2, 2016",2016-01-26 19:52:11 +0000,http://www.publicnow.com/view/03629E67079B58818FBA3F71903FA9144786247B,"[at noodls] - , /PRNewswire/ -- (Nasdaq: ARRY) will report financial results for the second quarter of fiscal 2016 and hold a conference call to discuss those results on , 2016. Ron Squarer, Chief Executive Officer, ..."
ARRY,ARRY:US,BBG000C52TW3,New Strong Buy Stocks for January 26th,2016-01-26 16:25:16 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0fkm6tumsz4/new-strong-buy-stocks-for-january-26th-cm570355,Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today 8Point3 Energy Partners LP ( CAFD )Array Biopharma Inc ( ARRY )Avianca Holdings SA ( AVH )Bank of Marin Bancorp ( BMRC )Black Stone Minerals
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference,2016-01-06 15:23:08 +0000,http://www.noodls.com/view/9AA00E2C50245A66E05E4EFC673B9D4882096871,"[at noodls] - , /PRNewswire/ -- (Nasdaq: ARRY) today announced that its Chief Executive Officer, , will speak at the Annual in San Francisco. The public is welcome to participate in the conference through a webcast ..."
ARRY,ARRY:US,BBG000C52TW3,Will Array BioPharma (ARRY) Crush Estimates at Its Next Earnings Report?,2016-01-06 15:17:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/aw7ebVWlpQI/will-array-biopharma-arry-crush-estimates-at-its-next-earnings-report-cm561817,"Looking for a stock that might be in a good position to beat earnings at its next report? Consider Array BioPharma Inc.ARRY , a firm in the biomedical industry, which could be a great candidate for another beat. This"
ARRY,ARRY:US,BBG000C52TW3,Why Array BioPharma (ARRY) Could Be Positioned for a Surge?,2015-12-23 15:19:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EBIhHo79aAw/why-array-biopharma-arry-could-be-positioned-for-a-surge-cm557977,"Array BioPharma Inc.ARRY is a biopharmaceutical company that could be an interesting play for investors. That is because, not only does the stock have decent short term momentum, but it is seeing solid activity on the earnings estimate revision"
ARRY,ARRY:US,BBG000C52TW3,Array Announces Closing Of Pierre Fabre Transaction,2015-12-21 12:13:10 +0000,http://www.noodls.com/view/C28F8CDDDA6BC00789F0BFAE0056ECC9CE19C386,"[at noodls] - , /PRNewswire/ -- (NASDAQ: ARRY) today announced the closing of its definitive agreement with following approval of the agreement by the (ECC). The definitive agreement, announced on , relates to globally ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma (ARRY) Jumps: Stock Moves Up 20.6%,2015-12-17 15:18:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1ghBQSCoFEQ/array-biopharma-arry-jumps-stock-moves-up-206-cm555892,"Array BioPharma Inc.ARRY was a big mover last session, as its shares rose nearly 21% on the day. The upside was driven by the company's announcement of a successful Phase 3 trial for its cancer drug binimetinib. This also"
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma Announces Phase 3 Binimetinib Trial Meets Primary Endpoint For NRAS-Mutant Melanoma,2015-12-16 12:15:29 +0000,http://www.noodls.com/view/B62E3E3EF204E76C1EC41BCCEAF94BB468D27B92,"[at noodls] - , /PRNewswire/ -- (Nasdaq: ARRY) today reported top-line results from the ongoing Phase 3 clinical trial of binimetinib in patients with advanced NRAS-mutant melanoma, known as the NEMO trial. The study ..."
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma reports 1Q loss,2015-11-04 13:29:36 +0000,http://sg.finance.yahoo.com/news/array-biopharma-reports-1q-loss-132936289.html,Array BioPharma reports 1Q loss
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma beats Street 3Q forecasts,2015-05-04 11:18:31 +0000,http://sg.finance.yahoo.com/news/array-biopharma-beats-street-3q-111831278.html,Array BioPharma beats Street 3Q forecasts
ARRY,ARRY:US,BBG000C52TW3,Array shares jump after drugmaker details Novartis deal,2015-01-23 17:02:43 +0000,http://sg.finance.yahoo.com/news/array-shares-jump-drugmaker-details-170243996.html,Array shares jump after drugmaker details Novartis deal
ARRY,ARRY:US,BBG000C52TW3,Array BioPharma meets 1Q profit forecasts,2014-11-04 14:09:58 +0000,http://sg.finance.yahoo.com/news/array-biopharma-meets-1q-profit-140958027--finance.html,Array BioPharma meets 1Q profit forecasts
